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CHAPTER I 
 
INTRODUCTION 
 
Mental Retardation (MR) is defined as a cognitive disability characterized by 
an overall intelligence quotient (IQ) lower than 70, which is associated with 
functional deficits in adaptive skills, including communication, self-care, ability to 
live independently, social and interpersonal skills, use of public services, decision 
making, functional academic skills, work, leisure, and health and safety, with onset 
before the age of 18 years (Ropers and Hamel, 2005; Chelly et al., 2006). MR 
affects 1-3% of general population, and therefore MR is one of the problems with 
the highest healthcare expenditure (Chelly et al., 2006). According to the 
classification by the World Health Organization, MR is subdivided into 5 
categories by IQ; Profound (IQ<20), Severe (20<IQ<35), Moderate (35<IQ<50), 
Mild (50<IQ<70), and borderline (70<IQ<80) (Ropers and Hamel, 2005). 
Causes of MR can be environmental, chromosomal, or monogenic.  
According to clinical observation and statistical data, there are significantly more 
male MR patients than females. The male to female ratio is about 1.4:1 in 
moderate to severe MR (IQ<50), while in mild MR the ratio is around 1.9:1 
(Leonard and Wen, 2002; Ropers, 2006). This sex bias has suggested that 
X-linked gene defects are important causes of MR. Up to 2006, 61 X-linked genes 
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were identified in MR disorders (Ropers and Hamel, 2005). X-linked mental 
retardation (XLMR) can be subdivided into syndromic forms and non-syndromic 
forms, according to whether other physical abnormalities are found in addition to 
mental retardation (Ropers and Hamel, 2005). There are about 140 syndromic 
XLMR diseases described. Fragile X Syndrome (FXS) is the most common cause 
of inherited mental retardation (Ropers and Hamel, 2005). 
 
Fragile X Syndrome 
Fragile X Syndrome (FXS) is the most common form of inherited mental 
retardation and the most common known genetic cause of autistic disorders. The 
disease occurs about one in 4000 males and one in 8000 females (Turner et al., 
1996; Reddy, 2005; Visootsak et al., 2005).  
Patients with FXS display several identifiable physical, behavioral and 
cognitive abnormalities. Physical symptoms include tall stature, large testes, long 
narrow face, prominent forehead, prominent mandible and large ears, and 
hyperextensibility of joints (Terracciano et al., 2005; Visootsak et al., 2005). These 
symptoms are more significant in male patients than in females, and tend to be 
more and more marked with age (Terracciano et al., 2005). Male FXS patients 
also display hyperactivity, attention deficits, social avoidance, anxiety in novel 
situations, sleep disorders, obsessive compulsive behaviors, stereotypic 
behaviors like hand flapping, and autistic features. Seizures are also present in 
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childhood but disappear with adolescence. Symptoms in female patients tend to 
be more subtle, which include shyness, poor eye contact, and attention deficits 
(Terracciano et al., 2005; Visootsak et al., 2005). Mild to severe mental retardation 
is the major symptom of FXS. The IQ of FXS patients is in the range of 20 to 70, 
with 40 as the average (Terracciano et al., 2005). Delays in language 
development are common in males, and both male and female patients display 
weakness on quantitative skills and short-term memory of visually represented 
abstract stimuli (Visootsak et al., 2005). In addition, 33% of FXS children have 
autism (Rogers et al., 2001). 
While mental retardation is the major symptom of FXS, the overall brain 
structure of patients is normal. There are only slight and debatable structural 
changes described, including diminished white-gray ratio, enlarged caudate 
nucleus and hippocampus, and a decreased cerebellar vermis with enlarged 
fourth ventricle (Terracciano et al., 2005). The only significant neuronal 
morphological anomalism described in human patients has been abnormal 
dendritic spines of pyramidal cells in layer III and V of parietooccipital neocortex 
(Hinton et al., 1991; Irwin et al., 2001). Compared with the mushroom-shaped 
normal mature dendritic spines, FXS patients display longer, thinner, and more 
tortuous dendritic spines. Spine density was also found increased in FXS patients 
(Irwin et al., 2000). 
The first literature report of FXS occurred in 1943 (O'Donnell and Warren, 
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2002; Visootsak et al., 2005). Martin and Bell described a large family with MR 
history, which displayed a strong sex bias with many more affected males than 
females. They concluded this mental retardation is caused by a X-chromosome 
linked recessive factor. In 1977, Sutherland found a fragile site on the distal long 
arm of X chromosome in FXS cells when cell culture media lacking folic acid was 
used (Sutherland, 1977). This phenotype is the basis of the current disease name. 
This fragile site was mapped to the position Xq27.3 (Proops and Webb, 1981). In 
1991, the gene causing the disease was identified (Verkerk et al., 1991). 
 
Fragile X Mental Retardation 1 (FMR1) Gene 
Fragile X syndrome is a single gene disorder, which is caused by loss of 
functional gene product of the Fragile X Mental Retardation 1 (FMR1) gene 
(Verkerk et al., 1991). FMR1 has 17 exons representing 40 kb total genomic 
length. The transcript can be spliced in alternate ways. Full length mRNA is about 
4kb and translated to a 69kDa protein, the Fragile X Mental Retardation Protein 
(FMRP) (Pieretti et al., 1991). FMR1 belongs to a highly conserved gene family, 
which includes two human autosomal paralogs, Fragile X Related 1 (FXR1) and 
Fragile X Related 2 (FXR2). Paralog genes were also identified in animals from 
Drosophila to zebrafish, to mouse (Ashley et al., 1993a; Siomi et al., 1995; Zhang 
et al., 1995; Wan et al., 2000).  
In the 5’ untranslated region (UTR) of FMR1, a CGG trinucleotide repeat 
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exists with variable length (Fu et al., 1991; Verkerk et al., 1991). In the general 
population, the copy number of the CGG repeat is 6 to 50 with 30 as average, 
which is stably transmitted across generations. The situation with 60 to 200 CGG 
copies has been called the FXS premutation, which is unstable and tends to 
expand through generations from female carriers to their offspring (Fu et al., 1991; 
Malter et al., 1997). The premutation carriers have been thought not to be affected. 
However, in recent years, a disease called Fragile X-associated tremor/ataxia 
syndrome was found in some aged male premutation carriers (Hagerman et al., 
2001), and 20% of female carriers showed ovarian dysfunction 
(Allingham-Hawkins et al., 1999; Hagerman and Hagerman, 2002). When the 
repeat number grows larger than 200, the situation is called the FXS full mutation. 
In this condition, the CGG repeats and upstream CpG islands are 
hypermethylated (Heitz et al., 1991), leading to silence the transcription of the 
downstream FMR1 gene and causing the disease (Figure 1.1A) (Zalfa and Bagni, 
2004). Using a methylation inhibitor to treat full mutation cells can rescue part of 
the FMRP expression (Chiurazzi et al., 1998). FXS can also arise because of 
missense mutations or deletions of encoding regions within the FMR1 gene 
(Gedeon et al., 1992; Wohrle et al., 1992; De Boulle et al., 1993). These results 
indicate that loss of the functional expression product of FMR1, FMRP, is the sole 
known cause of Fragile X syndrome. 
  
 
 
 
 
 
Figure1.1 FMR1 gene structure, Hypermethylation, and FMRP structure. 
A. The FMR1 gene has 17 exons over 40 kb of genomic length. A CGG repeat 
region presents in the 5’-untranslated region (UTR) of FMR1. In the normal 
situation, the CGG copy number is less than 50, and FMR1 is transcribed and 
translated at normal levels. When CGG copy number is from 55 to 200, which is 
called the premutation situation, there is a higher FMR1 mRNA level in cells, but 
the protein level is lower than normal. Premutation is an unstable situation, and 
expand to longer repeats when transmitted from female carriers to their offspring. 
When the CGG repeat is longer than 200 copies, the upstream regulatory region 
is hypermethylated, consequently silencing the transcription of downstream 
FMR1 gene. This is called the full mutation, which is the reason of most cases of 
Fragile X Mental Retardation.  
B. Human FMRP is a 69 kDa protein composed of 632 amino acids. FMRP 
contains 8 known functional domains, including one NLS (nuclear localization 
signal), one NES (nuclear export signal), two KH domains (pre-mRNA binding 
heterogeneous nuclear ribonucleoprotein K homology domains), one RGG 
(arginine-glycine-glycine) box, two coiled-coil domains, and one N-terminal motif 
implicated in both protein and mRNA binding. 
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Fragile X Mental Retardation Protein (FMRP) 
Human FMRP is composed of 632 amino acids and is expressed in most 
tissues, albeit with particular enrichment in the nervous system and testes (Hinds 
et al., 1993; Verheij et al., 1993). FMRP contains 8 known functional domains, 
including one NLS (nuclear localization signal), one NES (nuclear export signal), 
two KH domains (pre-mRNA binding heterogeneous nuclear ribonucleoprotein K 
homology domains), one RGG (arginine-glycine-glycine) box, two coiled-coil 
domains, and one N-terminal motif (Adinolfi et al., 1999a; Adinolfi et al., 2003; 
Zalfa and Bagni, 2004) (Figure 1.1B). 
The KH domain is an evolutionarily conserved motif from bacteria to human, 
which frequently presents in the heterogeneous nuclear ribonucleoprotein 
(hnRNP) family (Siomi et al., 1993). KH domains preferentially bind mRNA, 
although a specific sequence binding target has not yet been identified (Adinolfi et 
al., 1999b). Two KH domains present back to back in the middle region of FMRP. 
A missense point mutation (I304) has been identified in one FXS patient, who had 
normal copy number of CGG repeats but displayed very severe FXS symptoms. 
This point mutation shifted one isoleucine in the second KH domain to asparagine, 
and consequently altered the RNA-binding activity of FMRP and the assembly of 
the 80S ribosomal complex (De Boulle et al., 1993). This point mutation provided 
the community with the idea that the KH domains are essential to FMRP’s 
function. 
RGG box is a cluster of Arg-Gly-Gly repeats, which is also known as an RNA 
binding motif (Ghisolfi et al., 1992; Kiledjian and Dreyfuss, 1992). In the studies of 
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FMRP function, the RGG box was found specifically associated with an mRNA 
secondary structure G-quartet (Darnell et al., 2001; Schaeffer et al., 2001). 
Several identified or potential mRNA targets of FMRP contain G quartet structures 
(Darnell et al., 2001). The N-terminus of FMRP is not homologous to any known 
functional motif. However, it has also been shown to have a binding affinity to 
mRNA, and also is important for protein-protein interactive features of FMRP. This 
region is called the NDF fold (N-terminal domain of FMRP) (Adinolfi et al., 1999a; 
Ramos et al., 2006). Two coiled coil domains are also likely involved in 
protein-protein interactions. FMRP rarely exists in isolation, but mostly associates 
with large messenger ribonucleoprotein (mRNP) particles and binds 
polyribosomes (Siomi et al., 1996). 
FMRP has been suggested to have an affinity for about 4% of total brain 
mRNA. Based on immunoprecipitation pull-down, microarray analysis of mouse 
brain identified 432 mRNA binding with FMRP (Brown et al., 2001). FMRP is 
known to negatively regulate the translational level of several mRNA targets 
(Brown et al., 1998; Laggerbauer et al., 2001; Sung et al., 2003). Most of these 
targets are important for neuronal structure and function, including microtubule 
associated protein 1B (MAP1B)/Futsch (Zhang et al., 2001; Lu et al., 2004), 
α-subunit of calcium/calmodulin-dependent protein kinase II (α-CamKII) (Zalfa et 
al., 2003), GTPase Rac1 (Lee et al., 2003), myelin basic protein (Brown et al., 
1998), activity-regulated cytoskeleton associated protein (Arc)/Arg3.1 (Zalfa et al., 
2003), and postsynaptic density protein 95 (PSD95/DLG) (Todd et al., 2003a; 
Muddashetty et al., 2007). In addition, FMRP can bind its own mRNA and inhibit 
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translation of itself (Ashley et al., 1993b; Sung et al., 2000).  
The mechanisms of FMRP regulating mRNA translation are still unclear. It 
has been found, however, that FMRP interacts with Argonaute 1 (AGO1) (Caudy 
et al., 2002), Argonaute 2 (AGO2) (Caudy et al., 2002; Ishizuka et al., 2002), the 
RNA-induced silencing complex (RISC) (Caudy et al., 2002; Ishizuka et al., 2002), 
and double-stranded RNA-specific RNaseIII (Dicer) (Jin et al., 2004), which are all 
important components in microRNA and RNA interference (RNAi) pathways. 
These findings suggest FMRP may play a role in the regulation of mRNA stability, 
or regulate target translation though the microRNA pathway. Moreover, the small 
dendritic non-translatable RNA BC1 was found directly associated with both 
FMRP and FMRP target mRNA. Blocking BC1 reportedly inhibits regulation of 
FMRP to its targets, which suggests FMRP may recruit specific mRNA targets with 
the help of BC1 (Zalfa et al., 2003). FMRP is best described as a translation 
repressor, since most known FMRP direct targets were translated in a higher level 
in absence of FMRP (Laggerbauer et al., 2001; Li et al., 2001). And in 
postsynaptic terminals, neurotransmission activity-induced local protein synthesis 
is FMRP-dependent (Miyashiro et al., 2003; Todd et al., 2003a; Weiler et al., 
2004).  
The NLS and NES domains suggest that FMRP shuttles between the 
nucleus and cytoplasm (Eberhart et al., 1996; Adinolfi et al., 1999a). Although 
essentially all FMRP is found localized in cytoplasm, a small quantity has been 
reported in the nucleus (Feng et al., 1997). Furthermore, FMRP has been found 
associated with some nuclear proteins or shuttle proteins, for example, Nucleolin 
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(Ceman et al., 1999), 82-FIP (82 KDa FMRP interacting protein) (Bardoni et al., 
2003b), and NUFIP (nuclear FMRP interacting protein) (Bardoni et al., 1999; 
Bardoni et al., 2003a), which suggest FMRP may bind its target in nucleus and 
take part in mRNA transport from the nucleus. In the nervous system, almost all 
FMRP is found in neuronal soma cytosol, while both FMRP and FMR1 mRNA 
have been detected in neuronal processes and synaptic terminals (Weiler et al., 
1997; Antar et al., 2004; Antar et al., 2005; Antar et al., 2006). In dendrites, FMRP 
is a component of mRNA transport granules, whose movement is neuronal activity 
induced (Antar et al., 2004; Antar et al., 2005). Moreover, local translation of some 
cargo mRNAs has been found to be reduced in fmr1 null dendrites (Miyashiro et 
al., 2003). 
Putting all of these features together, FMRP is considered a RNA-binding 
protein, which may play a role in RNA transport, RNA stability, and translational 
regulation. The most strongly supported theory is that FMRP is a translational 
repressor.  
 
Animal Models of FXS 
The human FMR1 gene was identified in 1991 (Verkerk et al., 1991). It has 
two autosomal homologues in the human genome, and highly conserved 
homologues in mouse, chick, zebrafish and fruit fly (Laval et al., 1992; Siomi et al., 
1995; Zhang et al., 1995; Wan et al., 2000; van 't Padje et al., 2005). The first 
knockout (KO) mouse was generated in 1994 by inserting a neomycin resistance 
cassette into exon 5 of mouse FMR1 gene (Bakker, 1994). Little or no functional 
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FMRP protein is expressed in this KO mouse model, which therefore mimics the 
FXS full mutation situation of human patients. The FMR1 KO mouse displays 
some similar phenotypes with human symptoms, including enlarged testes in 
males (Bakker, 1994; Kooy et al., 1996), increased locomotor activity (Bakker, 
1994; Mineur et al., 2002), and increased audiogenic seizures susceptibility 
(Musumeci et al., 2000; Chen and Toth, 2001). Like human patients, the FMR1 
KO mouse has grossly normal brain structure, while denser, longer, and tortuous 
dendritic spines are also observed in the visual cortex of the KO mouse (Comery 
et al., 1997; Irwin et al., 2002). According to corticosterone level test, acute stress 
response is misregulated in FMR1 KO mice (Markham et al., 2006). In addition, 
KO mice displayed significant reduce on social interaction, which is comparable 
with autistic features in human patients (Mineur et al., 2006). In the Morris water 
maze test, FMR1 KO mouse displayed a mild impairment, indicative of a mild 
deficit in spatial learning (Bakker, 1994; Kooy et al., 1996; D'Hooge et al., 1997; 
Dobkin et al., 2000). The FMR1 KO mouse is deficient in leverpress 
escape/avoidance task test, which also suggests a learning defect (Brennan et al., 
2006) (Table1.1).  
The Drosophila FMR1 homologue (dFMR1, also known as dFXR, Drosophila 
Fragile X related) was characterized in 2000 (Wan et al., 2000). Whereas three 
FMR1 related genes (FMR1, FXR1, FXR2) are present in vertebrate genomes, 
Drosophila contains a single gene, which is similarly related with all three human 
counterparts. Since no homologue has been found in C.elegans or yeast, 
Drosophila FMR1 might be a prototype of this gene family (Wan et al., 2000).  
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Table 1.1 Phenotype Comparison of FXS patients and animal models 
             Human             Mouse             Drosophila 
Cognitive     MR                Learning deficits     short-term memory 
                                                    deficits 
 
Behavioral    Hyperactivity      Hyperactivity        Hyperactivity 
 
            Sleep Disorder      ND                 Circadian Arrhythmia 
 
              Autistic features    Autistic features     ND 
 
Testes        Macroorchidism     Macroorchidism      Macroorchidism 
 
Neuronal     Dendritic Pruning    Dendritic Pruning     Overgrowth & 
Structure     Defects             Defects             Overbranching 
 
Synapse     Excess Spines       Excess Spines       Excess Boutons 
 
Function     ND                 Increased LTD       Altered Plasticity 
                                 Decreased LTP 
MR, Mental Retardation; ND, Not determined; LTD, Long-term depression; LTP, Long-term 
Potentiation; EJC, Excitatory junctional current. Table is modified and updated from 
Zhang&Broadie, Trends in Genetics, 2005 
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dFMR1 is located on the Drosophila third chromosome cytological position and 
encodes a 681 amino acid protein, dFMRP (Drosophila fragile X mental 
retardation protein), which shares all functional domains with human FMRP 
(Figure1.2A) (Wan et al., 2000; Zhang et al., 2001). The first Drosophila FXS 
model was established in  the Broadie Lab in 2001 by deleting regulatory and 
part of coding regions of dFMR1 gene (Zhang et al., 2001). Several other dfmr1 
null alleles have been reported in more recent years (Dockendorff et al., 2002; 
Lee et al., 2003). Similar to mammalian FMRP, dFMRP is highly enriched in 
nervous system and testes (Wan et al., 2000; Zhang et al., 2001; Zhang et al., 
2004). Also similar to human FXS patients, dfmr1 mutant flies are viable, but 
display several behavioral defects, including locomotory problems (Zhang et al., 
2001; Xu et al., 2004), eclosion failure (Inoue et al., 2002; Morales et al., 2002), 
circadian rhythmic defects (Dockendorff et al., 2002; Inoue et al., 2002; Morales et 
al., 2002), and defective learning and memory (Dockendorff et al., 2002). dfmr1 
male flies also display enlarged testes, spermatogenesis and sterility defects 
(Zhang et al., 2004), while females display oogenesis defects (Costa et al., 2005). 
Overgrowth and overbranching neuronal processes were found in both central 
and peripheral nervous systems of dfmr1 mutant flies (Zhang et al., 2001; Lee et 
al., 2003; Pan et al., 2004) (Table1.1, and see below for detailed description).  
 
Defects of Neuronal Structure in fmr1 mutants 
As discussed above, loss of FMRP is associated with abnormal postsynaptic 
dendritic spines in Fragile X Syndrome (FXS) patients and in the mouse knockout 
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model, which are denser and morphologically altered compared to normal (Hinton 
et al., 1991; Irwin et al., 2001; Irwin et al., 2002). While similar dendritic spine 
abnormalities occur in other neurological diseases, including Down’s Syndrome 
and Alzheimer’s Disease (Purpura, 1974; Fiala et al., 2002), increased spine 
density appears to be a unique feature of FXS (Kooy, 2003). In the mouse FXS 
model, layer V pyramidal neurons in the visual cortex display longer, thinner, and 
tortuous spines rather than the normal short, mushroom-shaped mature spines 
(Irwin et al., 2002). The largest difference between normal and mutant dendritic 
spines has been found in the one week postnatal stage; and in mice older than 4 
weeks, these defects may be lost (Nimchinsky et al., 2001). During this period, 
spines normally display very active changes in length, density, and motility, which 
may reflect a developmental pruning stage dependent on FMRP. FXS mice also 
exhibit this apparent pruning defect in dendrites of spiny stellate cells in the inner 
barrel wall of layer IV somatosensory cortex, maintaining a septa-oriented 
morphology characteristic of an early development stage (Galvez et al., 2003). 
Such defects in dendritic spine pruning and maturation indicate that FMRP may 
regulate experience-dependent synaptogenesis.  
Our lab previously established a Drosophila FXS model to test the 
hypothesis that FMRP regulates synaptic differentiation, utilizing the 
well-characterized fly neuromuscular junction (NMJ) (Zhang et al., 2001). We 
showed that the level of dFMRP regulates both structural complexity and synaptic 
transmission strength; dfmr1 null mutants display overgrowth and overbranching, 
whereas dFMRP overexpression caused the opposite phenotypes of undergrowth
  
 
 
 
 
 
 
 
Figure1.2 Drosophila FXS Model 
A. Drosophila Fragile X Mental Retardation Protein (dFMRP) shares all the 
functional domains with human FMRP (hFMRP). aa, amino acid. Modified from 
Gao, FB, Neuron, 2002. 
B. In dfmr1 null flies, NMJ displayed more synaptic boutons and more branches 
than wild type, while dFMRP overexpression (OE) displayed opposite phenotypes. 
The scale bar equals 10 μm.  
C. At NMJ, evoked excitatory junctional current (EJC) was increased in dfmr1 null 
mutants, but no change in overexpression (OE).  
B&C are taken from Zhang, YQ et al., Cell, 2001. 
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and underbranching. Loss of dFMRP caused increase of bouton. Number and 
branch number at NMJ terminal (Zhang et al., 2001). Similar results were reported 
in another peripheral nervous system model, dendritic arborization (DA) neurons, 
which are a subtype of Drosophila peripheral sensory neurons (Lee et al., 2003). 
In DA neurons, dfmr1 mutants display increased higher-order sensory dendritic 
branching, whereas dFMRP overexpression inhibited dendritic branching and 
reduced the complexity of sensory processes. In my Ph.D thesis work, I examined 
dfmr1 mutant neuronal structure in the Mushroom Body (MB), the learning and 
memory center in Drosophila brain. dfmr1 null MB neurons display more complex 
neuronal structure, including overgrowth and overbranching in dendrites and axon, 
more excess processes from cell bodies, and abnormal synapse formation. In 
contrast, dFMRP overexpression simplified neuronal structure, causing 
undergrowth and underbranching. Another Drosophila FXS lab also reported that 
the Mushroom Body β-lobe displayed an over-extending phenotype, which 
caused the β-lobe axon crossing the midline between two Mushroom bodies. 
Taken together, these results suggest that dFMRP acts a negative regulator in 
both central and peripheral nervous systems to control the differentiation of 
neuronal architecture (Pan et al., 2004). 
 
Defects of Neuronal Plasticity in fmr1 mutants 
FMRP is believed to be a translation regulator, and it suppresses its own 
translation in a negative feedback loop (Weiler et al., 1997; Sung et al., 2003). 
Both FMRP and FMR1 mRNA were found localized in neuronal processes and 
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synaptic terminals (Weiler et al., 1997; Antar et al., 2004). These facts raise the 
speculation that FMRP regulates local protein synthesis at synaptic terminals, 
which is an important process in synaptic development and/or plasticity.  
In fmr1 knockout mice, hippocampal long-term depression (LTD), dependent 
on activation of the group I class 5 metabotropic glutamate receptor (mGluR) , is 
selectively enhanced (Huber et al., 2002; Koekkoek et al., 2005), while 
hippocampal long-term potentiation (LTP) is normal (Godfraind et al., 1996). This 
LTD increase is caused by aberrant GluR1 AMPA (α-amino-3-hydroxy-5-methyl- 
4-isoxazole propionic acid) glutamate receptor expression (Bear et al., 2004; 
Nosyreva and Huber, 2006) and local protein synthesis dependent. Treating fmr1 
KO mice with the mGluR5 antagonist MPEP, which blocks mGluR5 activity, can 
rescue two major FXS phenotypes, reduced habituation in open field tests and 
increased sensitivity to audiogenic seizures (Yan et al., 2005). Moreover, cerebral 
cortex LTP is reduced concomitant with reduced GluR1 expression in fmr1 mutant 
mouse (Li et al., 2002; Larson et al., 2005; Zhao et al., 2005). 
At the Drosophila NMJ, which is a glutamatergic synapse, evoked excitatory 
junctional current (EJC) is significantly increased in dfmr1 null mutants. In addition, 
quantal analysis showed that both the amplitude and frequency of spontaneous 
transmission are increased at the dfmr1 NMJ (Zhang et al., 2001). Ultrastructure 
analysis of dfmr1 mutants showed enlarged synaptic boutons, and abnormal 
synaptic vesicle accumulation in presynaptic boutons (Pan et al., 2004). These 
data suggest a neuronal transmission deficit in dfmr1 mutants. 
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Molecular Mechanism of FXS 
Loss of functional FMRP is the only known cause of Fragile X Syndrome, so 
the major efforts to understand molecular mechanism of FXS were to explore the 
function of FMRP. As an RNA binding protein, FMRP is believed to be a 
translational regulator, which may function in both neuronal soma and synaptic 
terminals. Therefore, a key question is to determine the downstream targets and 
downstream pathways that FMRP may regulate. 
The identification of the first direct target of FMRP, was when our lab first 
found that expression of Futsch, the Drosophila homologue of microtubule 
associated protein 1B (MAP1B), was down-regulated by dFMRP; and that 
FUTSCH mRNA can be immunoprecipitated by anti-FMRP antibody (Zhang et al., 
2001). Moreover, futsch; dfmr1 double mutations can rescue the synaptic 
structure and functional defects in dfmr1 null. This result was confirmed in fmr1 
KO mice; MAP1B expression is enhanced in the hippocampus of fmr1 mice and 
microtubule stability is increased in fmr1 mutant culture neurons (Lu et al., 2004). 
In another research system of dFMRP, the Drosophila testes, our lab found that 
the conventional 9+2 structure of microtubules in sperm tail axoneme was 
changed in dfmr1 mutants, with the two central pairs lost (Zhang et al., 2004). All 
these data suggest that FMRP may influence microtubule structure by regulating 
microtubule binding protein level. 
Also in the Drosophila model, other identified targets of dFMRP include the 
small GTPase Rac1 (Lee et al., 2003), and actin-binding Profilin (Reeve et al., 
2005), which are both important for actin dynamics and microfilament remodeling. 
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Both Rac1 and Profilin levels are increased in dfmr1 mutants. FMRP and GTPase 
Rac1 can both regulate the branching pattern of dendritic arborization (DA) 
neurons (Lee et al., 2003). Loss of dFMRP causes overbranching in DA dendries, 
and over-expression dFMRP causes underbranching. Rac1 mutants display 
opposite phenotypes to dfmr1 mutants; and co-overexpression of these two 
proteins can reverse dendritic branching to wild type level. A Similar relationship 
was also found between FMRP and Profilin (chickadee). Both of them regulate 
neuronal process patterning in Lateral Neurons (LNv), but do so in opposite 
directions. dProfilin; dfmr1 double mutants display normal pattern of LNv (Reeve 
et al., 2005). In addition, FMRP was also found interacted with CYFIP, a protein 
affecting axon growth and interacted with Rac1 pathway (Schenck et al., 2003). 
These results suggest FMRP may regulate actin dynamics and microfilament 
remodeling by regulating the levels of actin associated proteins. 
Furthermore in fmr1 KO mice, both MAP1B and activity-regulated 
cytoskeleton-associated protein (Arc) mRNA were found associated with FMRP 
and BC1 non-translatable RNA complex, and upregulated in fmr1 mutants (Zalfa 
et al., 2003). The cooperation between FMRP and BC1 RNA is one of the most 
potential mechanisms of FMRP recognizing and regulating its targets. Taken 
together, FMRP regulates the expression of several cytoskeleton associated 
proteins, consequently affecting cytoskeleton stability or remodeling in neuronal 
processes and synapses. This is therefore one attractive mechanism by which 
FMRP may contribute to neuronal elaboration and function (Figure1.3A). 
In fmr1 KO mice, the enhanced hippocampus LTD was a particularly exciting 
  
 
 
 
 
 
Figure 1.3 Molecular Mechanisms of FXS 
A. Cytoskeleton mechanism: Cytoskeleton associated proteins, including 
MAP1B/Futsch, Arc, CamKII, GTPase Rac1, are directly regulated by FMRP in a 
negative translation mechanism, consequently influence microtubule stability or 
actin reorganization and synaptic structure and functions.  
B. mGluR theory: In the normal situation, mGluR signal induced LTD is in situ 
protein synthesis dependent. Some newly expressed proteins are regulators of 
AMPA glutamate receptor membrane expression. FMRP may regulate the level of 
this process by inhibiting translation in a negative feedback loop. When FMRP is 
not available, some synthesis may not be initiated or protein synthesis is 
aberrantly constantly upregulated. Membrane-expressed AMPA receptor levels 
are abnormal, consequently resulting in increased LTD. Modified from Bagni and 
Greenough, 2005. 
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finding in the field. FMRP is a translation regulator, which presents in both pre- 
and postsynaptic terminals. Neurotransmitter-stimulated local protein synthesis is 
known to be essential for some types of synaptic plasticity (Schuman et al., 2006). 
In addition, FMRP is in situ translated at postsynaptic terminals (Weiler et al., 
1997; Todd et al., 2003b), a process stimulated, like other local synaptic protein 
synthesis, by group I mGluR5 activation (Huber et al., 2000; Huber et al., 2001; 
Weiler et al., 2004; Pfeiffer and Huber, 2006). All of these facts raised the support 
for the conclusion that FMRP function is related to synaptic plasticity. 
Both FMRP synaptic localization and expression are increased by 
glutamatergic activity, and this regulation is blocked by MPEP (mGluR5 antagonist) 
and increased by DHPG (mGluR5 agonist) (Weiler et al., 1997; Antar et al., 2004; 
Weiler et al., 2004; Hou et al., 2006). mGluR-dependent LTD is normally 
completely dependent on new translation, but in the absence of FMRP, mGluR5 
activation does not trigger protein synthesis (Weiler et al., 2004; Aschrafi et al., 
2005). Anisomycin, a translation inhibitor, can suppress mGluR5-induced LTD. 
However, this inhibitive response is lost and the DHPG-induced increase of 
synaptic proteins synthesis is reduced in fmr1 KO mice (Hou et al., 2006; 
Nosyreva and Huber, 2006). One outcome of mGluR5 activation is to regulate 
trafficking of AMPA GluRs (Carroll et al., 1999; Snyder et al., 2001; Xiao et al., 
2001; Nosyreva and Huber, 2005). Correspondingly, feeding dfmr1 mutant 
Drosophila with MPEP, as well as class II/III mGluR antagonists, can rescue some 
mutant phenotypes, including behavioral (courtship learning and memory) and 
morphological (mushroom body β-lobe over-extending) defects (McBride et al., 
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2005). These data suggest a mechanistic connection between mGluR signaling, 
the translation regulatory function of FMRP, and AMPA GluR expression: a 
hypothesis termed “the mGluR theory of FXS” (Bear et al., 2004). 
 
Aims and results in this work 
This work employs the Drosophila model to study cellular and molecular 
mechanism of Fragile X syndrome, including dFMRP’s function on neuronal 
elaboration, synaptogenesis, and synaptic plasticity. 
In the first part of this thesis work, I used a powerful genetic technique called 
Mosaic Analysis of Repressible Cell Marker (MARCM) to examine neuronal 
structure in Drosophila Mushroom Body (MB), a learning and memory center in 
the fly brain. Former results suggested dFMRP was a negative regulator of both 
axonal and dendritic elaboration in peripheral nerve system. My work examined 
this hypothesis in the central nervous system (CNS). I found that loss of dFMRP 
converts unipolar MB neurons into multipolar neurons. Both dendrites and axon 
display overgrowth and overbranching phenotypes in dfmr1 null mutants, which is 
consistent with peripheral nervous system (PNS) phenotypes. Moreover, 
ultrastructure analysis of dfmr1 mutants shows enlarged synaptic boutons, 
irregular bouton size, and abnormal vesicles accumulation in synaptic boutons, 
which indicate altered synaptogenesis and/or arrested synaptic function. 
Combined with former results, my data indicate that Drosophila FMRP is a 
negative regulator of the differentiation of neuronal architecture and synaptic 
connections in both PNS and CNS (Pan et al., 2004).  
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Beyond the cellular level, my next work investigated the molecular 
mechanisms underlying structural and functional defects in dfmr1 mutant neurons. 
In a series of tests for synaptic protein levels at the Drosophila NMJ, I found that 
the levels of AMPA-like ionotropic glutamate receptor subunits were changed in 
dfmr1 mutants. Associated with the “mGluR theory” hypothesis, I examined 
mechanistic links between dFMRP, DmGluRA and ionotropic GluR expression. 
Two GluR classes reside at this synapse, each containing common GluRIIC (III), 
IID and IIE subunits, and variable GluRIIA (A-class) or GluRIIB (B-class) subunits. 
In dfmr1 null mutants, A-class GluRs accumulate and B-class GluRs are lost, 
whereas total GluR levels do not change, resulting in a striking change in GluR 
subclass ratio at individual synapses. DmGluRA is the sole Drosophila mGluR, 
and is expressed at the NMJ. In dmGluRA null mutants, both ionotropic GluR 
classes increase, resulting in an increase in total synaptic GluR content but no 
change in GluR subclass ratio. In dfmr1; dmGluRA double null mutants, there is 
an additive increase in A-class GluRs, and a similar additive impact on B-class 
GluRs, towards normal levels in the double mutants. By overexpressing dFMRP 
or DmGluRA at either pre- or post synaptic terminals, I found the mechanism of 
FMRP regulating ionotropic GluRs was postsynaptic. These results show that 
dFMRP differentially regulates different GluR subclasses within a single synaptic 
terminal that DmGluRA negatively regulates in common these GluRs, but the 
dFMRP mechanism is at least somewhat independent of mGluR signaling with 
the two pathways converging to jointly control synaptic GluR abundance. 
To further elucidate the mechanistic relationship between dFMRP and 
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DmGluRA, I further tested behavioral performance, neuronal structure, and 
protein expression level, in both dfmr1 and dmGluRA mutants. I found dFMRP is 
upregulated in dmGluRA mutant CNS, and vice versa. dmGluRA mutants display 
a behavioral defect in coordinated movement, as revealed by a “roll over” assay, 
which can be rescued by removing dFMRP expression. The dfmr1 mutants 
display a series of neuronal structure defects at NMJ, including increased branch 
number, increased total bouton number, and increased total synaptic area. 
Blocking DmGluRA signaling can rescue the over-branching phenotype of dfmr1 
null, however with no significant effect on the increased total synaptic area. 
Conversely, the total bouton number is increased even more in absence of 
DmGluRA signaling in the dfmr1 null mutants. These data strongly suggest that 
both overlapping and independent mechanisms exist between dFMRP function 
and DmGluRA signaling in neuronal/synaptic regulation. 
Taken together, my studies showed that FMRP functions as a negative 
regulator of neuronal architecture. In addition, FMRP regulates synaptic function 
partially by interacting with metabotropic glutamate receptor signaling, and bring a 
new insight into the regulative function of FMRP to components of ionotropic 
glutamate receptors and neurotransmission control.  
 
CHAPTER II 
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Summary 
Fragile X Syndrome (FXS) is the most common form of inherited mental 
retardations. The disease is caused by silencing of the fragile X mental retardation 
1 (FMR1) gene, which encodes the RNA-binding, translational regulator FMRP. In 
FXS patients and fmr1 knockout mice, loss of FMRP causes denser and 
morphologically altered postsynaptic dendritic spines. Previously, we established 
a Drosophila FXS model, and showed that dFMRP acts as a negative 
translational regulator of Futsch/MAP1B, and negatively regulates synaptic 
branching and structural elaboration in the peripheral neuromuscular junction 
(NMJ). Here, we investigate the role of dFMRP in the central brain, focusing on 
the Mushroom Body (MB), the learning and memory center. In MB neurons, 
dFMRP bi-directionally regulates multiple levels of structural architecture, 
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including process formation from the soma, dendritic elaboration, axonal 
branching and synaptogenesis. Drosophila fmr1 (dfmr1) null mutant neurons 
display more complex architecture, including overgrowth, overbranching and 
abnormal synapse formation. In contrast, dFMRP overexpression simplifies 
neuronal structure, causing undergrowth, underbranching and loss of synapse 
differentiation. Ultrastructural studies of dfmr1 mutant neurons reveal enlarged 
and irregular synaptic boutons with dense accumulation of synaptic vesicles. 
Taken together, these data show that dFMRP is a potent negative regulator of 
neuronal architecture and synaptic differentiation in both peripheral and central 
nervous system. 
 
Introduction 
The fragile X mental retardation protein (FMRP) is a negative translational 
regulator whose known targets include prominent regulators of the neuronal 
cytoskeleton such as Futsch/MAP1B (Zhang et al., 2001; Zalfa et al., 2003), 
Arc/Arg3.1 (Zalfa et al., 2003), α-CamKII (Zalfa et al., 2003) and FMRP itself 
(Schaeffer et al., 2001). Loss of FMRP is associated with abnormal postsynaptic 
dendritic spines in Fragile X Syndrome patients and in the mouse knockout model, 
which are denser and morphologically altered compared to normal (Rudelli et al., 
1985; Hinton et al., 1991; Irwin et al., 2001). While dendritic spine abnormalities 
occur in other neurological diseases, including Down’s Syndrome and Alzheimer’s 
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Disease (Purpura, 1974; Fiala et al., 2002;), increased spine density appears to 
be a unique feature of FXS (Irwin et al., 2000; Kooy, 2003). Such defects in 
dendritic spine pruning and maturation may indicate that FMRP regulates 
experience-dependent synaptogenesis. While basal synaptic function appears 
relatively normal in mutant mice, hippocampal long-term depression (LTD) 
dependent on activation of metabotropic glutamate receptors is selectively 
enhanced (Huber et al., 2002). It is, therefore, enticing to speculate that synaptic 
structural and functional defects underlie fragile X mental retardation and 
cognitive deficits.  
We previously established a Drosophila FXS model to test the hypothesis 
that FMRP regulates synaptic differentiation, utilizing the well-characterized 
neuromuscular junction (NMJ; Zhang et al., 2001). We showed that the level of 
Drosophila FMRP (dFMRP) regulates both structural complexity and synaptic 
transmission strength; dfmr1 null mutants display overgrowth/overbranching and 
strengthened transmission, whereas dFMRP overexpression caused the opposite 
phenotype of undergrowth/underbranching (Zhang et al., 2001). Similar results 
were also reported in another peripheral nervous system model, dendritic 
arborization (DA) neurons, which are a subtype of Drosophila peripheral sensory 
neurons (Lee et al., 2003). In DA neurons, dfmr1 mutants display increased 
higher-order sensory dendritic branching, whereas dFMRP overexpression 
inhibits dendritic branching and reduces the complexity of sensory processes. 
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While both NMJ and DA sensory neurons are tractable systems in which to study 
neuronal morphology, the mechanisms governing central neurons might be very 
different. In the adult Drosophila brain, dorsal cluster (DC) and lateral neurons 
(LNv) have been reported to display highly variable phenotypes in dfmr1 mutants 
(Morales et al., 2002). In DC neurons, both null mutants and dFMRP 
overexpression reportedly result in similar phenotypes; decreased neuronal 
extension and irregular neuronal branching. However, in LNv processes, dfmr1 
mutants reportedly display over-extension phenotypes. In addition, axon guidance 
defects were reported in both DC and LNv neurons. At the same time, 
photoreceptor neurons are reportedly morphologically normal (Dockendorff et al., 
2002; Morales et al., 2002). These results are confounding, suggesting that 
dFMRP may differentially regulate peripheral and central neurons, or play different 
roles in neuronal subtypes.  
Given the importance of understanding the role of dFMRP in central neurons, 
particularly in behavioral circuits most relevant to FXS cognitive symptoms, we 
undertook an in-depth examination of the mushroom body, the learning and 
memory center of Drosophila brain (Davis and Han, 1996; Heisenberg, 1998; 
Heisenberg, 2003). Due to its inherent complexity, it is technically very difficult to 
study neuronal morphogenesis in the brain using conventional techniques. We 
therefore used the MARCM (mosaic analysis with a repressible cell marker) 
system developed by Lee and Luo (1999), which labels single homozygous 
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mutant neurons uniquely, to reveal the whole projections of labeled neurons in the 
intact brain. We show here that the level of dFMRP tightly regulates neuronal 
structure, including formation of cell body processes, dendritic elaboration, axon 
branching, and synapse formation in mushroom body neurons. These central 
phenotypes are strikingly similar to our earlier report of peripheral phenotypes at 
the NMJ (Zhang et al., 2001). Ultrastructure analysis of dfmr1 mutants show 
enlarged synaptic boutons, irregular bouton size, and abnormal vesicles 
accumulation in synaptic boutons, which indicate altered synaptogenesis and 
arrested synaptic function. Taken together, these data suggest that dFMRP acts a 
negative regulator in the brain to control the differentiation of neuronal 
architecture and synaptic connections. 
 
Results 
 
dFMRP is expressed primarily in the neuronal soma in Mushroom Body 
We previously showed in the Drosophila 3rd instar larva, that dFMRP is 
enriched in neuronal soma cytoplasm, undetectable in neuronal nuclei, and 
present at only a very low level in neuronal processes (Zhang et al., 2001). 
Likewise in larval sensory dendritic arborization (DA) neurons, dFMRP is highly 
enriched in soma and present at very low levels in sensory dendrites (Lee et al., 
2003). Both mammalian and Drosophila FMRP is also enriched in adult brain, 
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specifically in neurons and glia progenitor cells but not mature glia (Devys et al., 
1993; Morales et al., 2002; Wang et al., 2004). In rat brain, FMRP is found 
primarily in neuronal soma, absent from nuclei, with a very small percentage of 
the protein present in neuronal processes, including postsynaptic dendritic spines 
(Feng et al., 1997; Weiler et al., 1997). To understand if dFMRP plays a role in the 
mushroom body (MB), we first assayed the expression pattern of dFMRP in MB 
neurons. 
To delineate MB neurons, we used the UAS-GAL4 system, in which a 
tissue-specific GAL4 transcription factor activates expression of a target gene by 
binding with its upstream activating sequence (UAS; Brand and Perrimon, 1993; 
Fischer et al., 1988). Here, UAS-mouseCD8-GFP driven by GAL4-OK107 labels 
the whole MB (Figure 2.1; Connolly et al., 1996). Double labeling of mushroom 
body with mCD8-GFP driven by OK107-GAL4 and anti-dFMRP antibody showed 
that dFMRP is expressed in the mushroom body neurons in a level similar to that 
of neighboring neurons (Figure 2.1A). dFMRP is prominently enriched in the soma 
of all MB neurons, but is undetectable in nuclei. The protein is clearly present at 
highest levels only within the cell body cytoplasm, with little or no detectable 
dFMRP in the dendrites and axonal lobes of MB neurons (Figure 2.1A). As a 
positive control, we labeled the MB with an antibody against Discs Large (DLG), a 
Drosophila homolog of postsynaptic density protein 95 (PSD95). Unlike dFMRP, 
DLG is prominently expressed in the dendritic arbor of MB neurons, as expected
  
 
 
 
 
 
 
Figure 2.1. dFMRP is primarily localized in the soma of Mushroom Body 
neurons. 
The whole mushroom body is labeled by UAS-CD8-GFP (green) driven by 
GAL4-OK107. The cell bodies, dendrites and axons are indicated.  
A. dFMRP expression (red) is predominantly present in soma, undetectable in 
dendrites and axons.  
B. Discs Large (DLG; red), a synaptic maker, as a positive control. Expression 
clearly observed in the MB neuropil. Scale bar = 10 μm. 
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 (Figure 2.1B). Thus, dFMRP is primarily restricted to neuronal soma. 
 
Mushroom Body structure is largely normal in dfmr1 null mutants 
There are three types of neurons in the Drosophila MB: γ, α’/β’, and α/β (Lee 
et al., 1999). In development, γ neurons are born first, soon after larval hatching, 
and their axonal projections form only one horizontal lobe in the adult MB. α’/β’ 
neurons are born second, between the mid-3rd instar and puparium formation, 
and lastly α/β neurons are born after puparium formation. In contrast to the single 
horizontal projection of γ neurons, both α’/β’, and α/β neurons have two axon 
projections, horizontal and vertical. The adult MBs display four specific structural 
clusters, including cell bodies, dendrites (also known as calyx), peduncle, and the 
axon lobes (Figure 2.2B). We took advantage of the relative simplicity of these MB 
neurons to analyze the requirement for dFMRP in their morphological 
differentiation. In this work, to make sure all phenotypes are caused by dfmr1 
mutation, we used two independently generated null mutant alleles of dfmr1, 
which represent over-lapping intragenic deficiencies; dfmr150M (Zhang et al., 2001) 
and dfmr13 (Dockendorff et al., 2002) (Figure 2.2A). In addition, we 
overexpressed dFMRP in targeted MB neurons to examine the consequence of 
excess protein. 
In both FXS patients and fmr1 KO mice, brain morphology is grossly normal 
  
 
 
 
 
Figure 2.2. dFMRP loss-of-function Mushroom Body has gross normal 
morphology. 
A. Genomic structure of the dfmr1 locus and the two independent dfmr1 intragenic 
deletion mutants used in this study; dfmr150M (Zhang, et al., 2001) and dfmr13 
(Dockendorff, et al., 2002). Note that dfmr13 deletion reported here has verified 
breakpoints that differ from reported in Dockendorff, et al., 2002.  
B. Whole mushroom morphology revealed by large neuroblast MARCM clones, 
labeled by UAS-CD8-GFP driven by GAL4-OK107. Wild type (WT) MB structure 
showing the labeled axon lobes (Lee et al., 1999). Occasional axon extension 
beyond the β lobe is observed. The dfmr1 null mutants display grossly normal MB 
structure. Mild β lobe overgrowth was also observed at a slightly higher frequency 
than wild type. In contrast, dFMRP overexpression (dfmrOE mutant) caused a high 
frequency of apparently random growth of all axon lobes. Especially in β lobe, 
dramatic overgrowth was observed at high frequency. All scale bars = 25 μm. 
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with no detectable abnormalities in any specific brain regions (Bakker, 1994; 
Reyniers et al., 1999). Similarly, null dfmr1 mutants display normal gross brain 
morphology, including an anatomically normal MB (Figure 2.2B). Mild overgrowth 
of the MB β lobe was observed in the null mutants. In contrast, dFMRP 
overexpression (OE) caused dramatic structural defects in MB axon lobes 
(Figure2.2B); the β lobe always over-extended across the midline, fusing the two 
MBs, the β’ lobe often displayed an apparently random direction of axon projection 
outside of the normal MB domain, and the γ lobe always displayed a dramatic 
decrease in volume, or was even completely lost (Figure 2.2B). Thus, dfmr1 null 
mutants display only subtle phenotypes at a gross MB level, whereas dfmr1 OE 
mutants display dramatic defects. Since FXS is caused by loss of FMRP, we 
therefore turned our attention to the single cell and subcellular level to examine 
neuronal architecture.  
 
Loss of dFMRP converts unipolar neurons into multipolar neurons 
The MARCM technique (Lee and Luo, 1999) provides a uniquely powerful 
approach to examine homozygous mutant neurons in situ at a single cell level of 
resolution. In this technique, a repressor of GAL4 gene activation, the GAL80 
gene, is placed in trans with the mutant gene, dfmr1. After induced mitotic 
recombination, homozygous mutant neurons express a GAL4-driven cell maker 
(e.g.UAS-GFP) because GAL80 is absent, whereas non-mutant neurons maintain 
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GAL80, silencing GAL4-drived gene expression (Figure 2.3). All the analyses 
presented in this study represent quantification from single cell clones, where only 
a single neuron in the mushroom body is labeled (Figure 2.3). We examine, in turn, 
each region of the mutant neuron, progressing from the cell body, through 
dendrites, axons and synapses. 
Drosophila MB neurons are exclusively unipolar (Crittenden et al., 1998; Lee 
et al., 1999). The cell bodies of MB neurons extend only a single primary process, 
which subsequently branches to form distinctive dendrites and a single axon 
projection (Figure 2.3A). A minority of wild type cells displays 1-2 tiny hair-like 
projections, but these additional processes are always very short and thin 
compared with the primary process. In wild type animal, it is exceptionally rare for 
the secondary processes to contain any branches or varicosities indicating 
functional differentiation (Figure 2.3A). In contrast, dfmr1 mutant cell bodies have 
a strong tendency to extend excess processes, thus always converting the 
characteristic unipolar neurons in wild type into multipolar neurons in mutants 
(Figure 2.3A). In addition, the supernumerary processes in dfmr1 mutants are 
usually long and thick, posses a clear branching structure and usually contain 
varicosities characteristic of synaptic boutons (Figure 2.3A). Correspondingly, 
dFMRP overexpression (OE) mutants display even fewer processes than wild 
type neurons. With excess dFMRP protein, most MB cell bodies are extremely 
clean, with no excess processes in addition to the primary process (Figure 2.3A).  
  
 
 
 
 
 
Figure 2.3. dFMRP loss-of-function results in aberrant multipolar neurons. 
A. Representative images of α’/β’ neuronal soma and processes in single-cell 
MARCM clones. Wild type (WT) neurons are typically unipolar, with at rare 
frequency 1-2 other short process (arrow). These tiny processes lack secondary 
branches. Overexpression of dFMRP (OE) results in a cleaner cell body, with no 
excess processes. In contrast, dfmr1 null mutant neurons always display multiple 
processes (arrows), becoming characteristically multipolar. These supernumerary 
processes are almost always multiply-branched and contain varicosities 
resembling synaptic boutons. Scale bar = 5 μm.  
B. Quantification of the number of processes projecting from cell bodies. Bars 
show mean ± SEM. Significance,: 0.001<P<0.05 (*); 0.0001<P<0.001 (**).  
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We quantified the number of supernumerary processes in single α’/β’ neurons. 
Null mutants display a 3-fold increase in the number of cell body processes (WT, 
1.27±0.3 (n=11); dfmr150M, 3.84±0.53 (n=19); dfmr13, 3.75±0.72 (n=12)), whereas 
dFMRP overexpression reduces the number of processes 2-fold (WT, 1.27±0.3 
(n=11); dfmr1OE, 0.64±0.2 (n=22)). Similar phenotypes were also observed in γ 
and α/β neurons. These data show that dFMRP strongly negatively regulates the 
generation of processes from neuronal cell bodies. 
 
dFMRP negatively regulates dendritic branching and arbor elaboration  
Although the dendritic arbors of all three types of MB neurons are elaborate 
and distinctive, common features of their dendritic structure aid in the description 
of the dfmr1 mutant phenotypes. Late-born α/β neurons (mitotic recombination 
was induced >12 hours after pupa formation; Zhu et al., 2003) were used for 
comparative studies. Four features in particular were subject to analyses. First, 
wild type MB neurons have 3-4 primary dendritic branches. Second, wild type 
primary branches project from the main process with a regular spacing of ~7 μm. 
Third, wild type primary branches rarely contain higher-order branches. Finally,  
primary branches end with a fine dendritic terminal arbor, forming a highly 
characteristic “claw-like” structure (Figure 2.4; Zhu et al., 2003). We used these 
conserved features as a basis to analyze the effect of dFMRP levels on dendrite 
morphogenesis.  
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Dendrites on dfmr1 null mutant neurons are consistently abnormal in 
morphology and projection, owing to changes in the number and arrangement of 
dendritic processes and increased variability of structural features (Figure 2.4). 
The number of primary dendritic branches are more variable in the mutant, 
ranging from 2-6 (compared to 3-4 in wild type). In addition, the spacing between 
these branches becomes extremely variable in the null mutant, from <3 μm to >20 
μm, compared to the consistent ~7 μm spacing in wild type (Figure 2.4). More 
visually striking, most mutant dendrite processes have clear supernumerary 
higher-order branches, and the clustered fine dendritic arbors normally restricted 
to the extreme termini (the “claw-like” structure; Zhu et al., 2003), spread 
aberrantly along the entire length of dendritic branches. These excess fine 
dendritic processes convert the clear, orderly wild type dendrites into disordered, 
“cotton wool-like” dendrites in dfmr1 mutants (Figure 2.4). On the other hand, 
dFMRP overexpression mutants lose the clustered fine dendritic arbors, and 
show severe reduction or complete loss of the claw-like structure at the terminal 
of dendritic branches (Figure 2.4). Excess dFMRP also results in longer, less 
structurally complex dendrites, which therefore take on the general appearance of 
axons. Thus, removal of dFMRP increases the branching and structural 
complexity of dendritic processes, whereas overexpression of dFMRP decreases 
dendritic branching and simplifies the arbor. These data show that dFMRP 
functions as a negative regulator of dendritic elaboration. 
   
 
 
 
 
 
Figure 2.4. dFMRP negatively regulates dendrite elaboration. 
Representative images of late-born α/β neuron dendrites in single-cell MARCM 
clones. Wild type (WT) dendrites typically display three primary branches, 
arranged in regular spacing of ~7μm. There are no high-order branches, but only 
a single, well-defined “claw-like structure” of fine processes at the termini (arrows). 
Three images of dfmr1 null mutant neuron dendrites show more complex and 
disordered structure. Spaces between primary branches become extremely 
variable. Primary dendrites display clearly secondary branches. The fine dendritic 
processes normally restricted to the termini, spread aberrantly along the primary 
branches. These defects convert the orderly wild type dendrites into disordered, 
“cotton wool-like” structures. dFMRP overexpression results in loss of the 
claw-like termini. Arrows show the reduced or absent claw-like structures. Scale 
bar =10 μm.  
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dFMRP negatively regulates axonal branching 
Progressing from the cell body and through the dendritic arbor, we next 
consider the role of dFMRP on axonal projection and structure. We first assayed 
the γ neuron because it has only one axonal branch and a particularly simple 
elaborative pattern in the adult MB. The wild type γ axon enters the horizontal MB 
axon lobe from the bottom edge, bends upwards to enter the γ lobe and 
terminates near the top boundary of the horizontal lobe (Figure 2.5A). The wild 
type γ neuron never branches prior to entering the γ lobe, but then typically has 
specific small branches along the main process (Lee et al., 1999). We assayed 
axonal morphology in dfmr1 null mutant neurons and in neurons overexpressing 
dFMRP. 
The axons of dfmr1 null mutant γ neurons are more structurally elaborate the 
wild type cells. Mutant neurons always display significantly increased axonal 
branching, and always have significantly more and longer axonal branches 
(Figure 2.5A). These large, supernumerary branches do not follow the main axon 
trajectory, but rather extend in apparently random directions to invade 
inappropriate territory (Figure 2.5A). Mutant axons not only join the γ lobe and 
arrive at the top boundary of horizontal lobe, but also inappropriately enter the β 
lobe at the bottom boundary and the β’ lobe at middle part of the horizontal lobe. 
Some of the excess branches in mutants are so large that it appears that the γ 
neuron possesses duplicated main axonal processes (Figure 2.5A). The number  
  
 
 
 
 
Figure 2.5. dFMRP negatively regulates axonal branching. 
A. Representative γ neuron axons in single-cell MARCM clones. The γ neuron 
axon normally enters the horizontal axon lobe from the bottom edge, bends 
upwards to enter the γ lobe and finally projects to the top boundary of horizontal 
lobe. In wild type (WT) neurons, the axon projection has only one main axonal 
branch with some specific small branches (arrows) along the main process. 
dFMRP over-expression (OE) causes dramatic underbranching of the axon. The γ 
neurons keep their processes along the bottom edge of the horizontal lobe and 
aberrantly invade the β lobe. The dfmr1 null mutants display the opposite 
phenotype of axonal overbranching. Null mutant neurons always have more and 
longer axonal branches. These large branches don’t follow the main axon 
direction, but rather extend in an apparently random direction (arrows). Scale bar 
=10μm. 
B. Quantification of the large branches (>5μm) for a single γ axon.  
C. Quantification of total branch length of a single γ axon. WT, n=19; dfmr150M, 
n=21; dfmr13, n=13; OE, n=24. Bars show mean ± SEM. Significance 
0.001<P<0.05 (*); 0.0001<P<0.001 (**); P<0.0001 (***). 
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of these large branches (>5 μm in length) increased on average by >50% (WT, 
3.74±0.28, n=19; dfmr13, 6.46±0.8, n=13; dfmr150M, 5.33±0.33, n=21; Figure 2.5B), 
and the total length of all axon branches also significantly increased (WT, 
65.68±5.07 μm; dfmr13, 103.33±8.5 μm; dfmr150M, 84.29±5 μm; Figure 2.5C). 
Correspondingly, overexpression of dFMRP caused dramatic under-branching in 
the γ neuron axon. Overexpression (OE) mutant neurons lose most or all of the 
normal axonal branches (Figure 2.5A). At the same time, most dFMRP 
overexpression γ neurons maintain their processes along the bottom edge of the 
horizontal lobe and aberrantly invade the β lobe. With excess dFMRP, the number 
of axonal branches was decreased by 65% (WT, 3.74±0.28, n=19; dfmr1OE, 
1.38±0.26, n=24; Figure 2.5B) and the total axonal branch length was decreased 
by 75% (WT, 65.68±5.07 μm; dfmr1OE, 16.86±3.8; Figure 2.5C). Thus, excess 
FMRP dramatically simplifies axonal projection and results in premature 
termination. 
Similar phenotypes were observed in the other two classes of MB neurons. 
Wild type α’/β’ neurons, for example, characteristically have one small side 
branch in the proximal quarter region of the primary axon process, and then small 
branches that cluster at the terminal of the horizontal lobes. Between this proximal 
branch and the terminal branching region, wild type α’/β’ neurons never contain 
branches along the axon process (Figure 2.6A; Lee et al., 1999). In contrast, 
dfmr1 null mutants display larger branches in both the proximal quarter region and 
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the terminal of α’/β’ axons, and supernumerary branches in the interspace region 
(Figure 2.6A). Correspondingly, dfmr1 OE mutants mostly lose this characteristic 
axonal branching pattern (Figure 2.6A). In addition, OE mutants often do not stop 
at the end of horizontal lobe, but usually turn up or down to form an aberrant hook 
at the terminus (Figure 2.6A). Similarly in α/β neurons, null dfmr1 mutant display 
excessive α processes. These results demonstrate that dFMRP functions to 
negatively regulate axonal branching in MB neurons, resulting in defective axonal 
guidance and connectivity. 
 
dFMRP regulates synaptic size and differentiation  
Loss of dFMRP results in striking defects in neuronal architecture (Figure 
2.3-2.6), suggesting that synaptic connectivity should be impaired. These 
structural defects may be the primary manifestation of the dfmr1 mutation, or may 
be a secondary consequence of impaired synaptic differentiation. Recent work in 
mouse fmr1 mutants have indicated defects in synaptic plasticity, suggesting 
specific problems in synaptogenesis, synaptic function or both (Huber et al., 
2002). Likewise, our previous work on dfmr1 mutants in the Drosophila NMJ and 
eye has strongly suggested specific defects at the synapse (Zhang et al., 2001). 
We therefore next examined synaptic differentiation in dfmr1 mutant MB clones at 
both the light and electron microscopy levels. 
In wild type animals, the axonal processes of MB neurons display a relatively 
 51
 52
smooth profile, with only subtle swellings, or varicosities, marking the sites of 
presynaptic boutons forming en passé connections (Figure 2.5A (γ neuron) and 
2.6A (α’/β’ neuron)). In comparison, dfmr1 mutant axons show a markedly 
discontinuous profile, with large puncta-like varicosity structures fairly evenly 
distributed along the axons, producing a highly characteristic “beads on a string” 
appearance (Figure 2.5A, 2.6A). The position and spacing of these varicosities 
strongly suggests that they represent enlarged or otherwise abnormal synaptic 
boutons. Correspondingly, overexpression of dFMRP resulted in reduction in the 
appearance of these presumptive synaptic boutons (Figure 2.5A, 2.6A). Thus, at 
a light microscope level, it appears that the level of dFMRP plays some prominent 
role in the regulation of synapse formation or differentiation. 
To confirm the identity of these presumed synaptic boutons, and to examine 
in detail synaptic differentiation in dfmr1 mutants, we next employed electron 
microscopy to examine MARCM mutant clones. For EM labeling, we used a 
peroxidase-conjugated anti-CD8 antibody followed by a Ni2+-enhanced DAB 
reaction to produce an electron-dense, membrane-associated signal clearly 
marking the dfmr1 mutant neurons (Figure 2.6D, and see Methods). We focused 
our analysis on α’/β’ axons in the horizontal axon lobe (Figure 2.6C), which show 
an extensive over-branching phenotype and prominently enlarged varicosities at 
the light microscope level (Figure 2.6A).  
 
  
 
 
 
Figure 2.6.  Altered synaptogenesis in dfmr1 mutants 
A. Representative α’/β’ neuron axon morphologies in single-cell MARCM clones. 
Wild type (WT) neurons characteristically have one small side branch in proximal 
quarter region, and branches clustered at the terminal of the horizontal lobes 
(arrowheads). Note that GFP distribution is relatively even along the axon, with 
only small varicosities. Two null dfmr1 mutant neuron axons display over- 
branching. Axons have longer side branches in proximal quarter and the terminal 
region. Extra branches (arrowheads) are observed between the proximal quarter 
and the terminal branching region. The GFP distribution is strikingly altered, with 
enlarged puncta (arrows) distributed along the axons. dFMRP overexpression 
(OE mutant) causes the loss of the characteristic branches. There is no branch in 
proximal quarter and terminal branching region. Arrowheads indicate the positions 
should have typical branches in WT axon. Scale bar = 20 μm.  
B. DAB stained brain revealing a large MARCM clone within the Mushroom Body. 
Scale bar = 100 μm.  
C. Confocal image of the whole Mushroom Body MARCM clone. Quadrangle 
represents the plane of section through the horizontal lobe, where all electron 
micrographs were taken. Scale bar = 10 μm.  
D&E. 11500X (D) and 40000X (E) electron micrograph of the Mushroom Body 
horizontal lobe. Labeled MARCM clone cells are marked with (L), unlabeled 
profiles (U), synaptic vesicles (SV), and mitochondria (M). Arrowheads indicate 
labeled membranes, and arrows indicate active zones. All scale bars = 500 nm. 
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Presynaptic specializations were defined based on the presence of 
electron-dense T-bars at active zones (Broadie and Richmond, 2002). The first 
objective was to determine whether the enlarged varicosities observed in mutant 
neurons at the light microscope level represent synaptic boutons. We therefore 
serial sectioned labeled α’/β’ axons and measured the cross-section area of any 
profile containing T-bar active zones (Figure 2.6D, E). The average bouton area 
of dfmr1 mutant clones was significantly (P<0.05) enlarged compared to labeled 
wild type clones (WT, mean= 0.199 ± 0.012 μm2, n=97; dfmr150M, mean=0.243 ± 
0.018, n=108) (Figure 2.7B). These results confirmed the impression from light 
microscope analyses (Figure 2.6A). In addition, dfmr1 null mutant boutons display 
a markedly more variable distribution of area than wild type boutons. In the 200+ 
boutons measured of both WT and mutant genotypes, the largest and smallest 
bouton ranges both occurred in mutant neurons (Figure 2.7B); the area of largest 
dfmr1 bouton was >50% larger than the largest wild type bouton, and the area of 
smallest dfmr1 bouton was ~35% decreased compared to the smallest wild type 
bouton. These results indicate that dFMRP negatively regulates the 
morphological differentiation of synaptic boutons, and also increases the fidelity 
of bouton size. 
 
dFMRP regulates ultrastructural differentiation of synapses 
Synaptic dysfunction may be a primary mutant phenotype in dfmr1 mutants, 
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leading secondarily to branch sprouting, aberrant growth and further synaptic 
differentiation as compromised cells seek in vain for synaptic partners. We 
therefore examined the synaptic ultrastructure of MARCM-labeled dfmr1 mutant 
MB neurons and performed a nearest-neighbor comparison with unlabeled 
control neurons. Labeled mutant α’/β’ neuron axon profiles in the MB displayed 
thick, darkly labeled plasma membrane in the electron microscope, which 
unambiguously marked mutant cells relative to adjacent, unlabeled control cells 
(Figure 2.6D,E).  
The immediately striking observation was that dfmr1 mutant presynaptic 
boutons were almost filled with evenly-sized, electron-lucent synaptic vesicles, 
clearly several orders of magnitude more vesicles than in control boutons (Figure 
2.6E, 2.7A and 2.7C). Indeed, vesicle density within the mutant boutons was so 
high that it often precluded the ability to resolve other features of the active zone 
and effectively prevented any ability to clearly resolve all individual vesicles for 
quantification. Therefore, to partially quantify the vesicle accumulation phenotype, 
we measured the area of bouton fully occupied by vesicles as a percentage of the 
total bouton area (Figure 2.7D). In control neurons, slightly less than 50% of the 
bouton area is normally occupied by synaptic vesicles, whereas in dfmr1 mutant 
neurons nearly 75% of the bouton is occupied by vesicles. Thus, the average 
area occupied by vesicles is 50% increased (P<0.001) in dfmr1 boutons 
compared to internal control boutons (Figure 2.6E and 2.7A, C, D). In fact, the  
  
 
 
 
 
Figure 2.7. dfmr1 mutants display enlarged synaptic boutons filled with 
vesicles. 
A. Electron micrograph (25000X) of a Mushroom Body horizontal lobe with wild 
type (WT, left) and dfmr150M (right) MARCM clones. Arrows indicate the 
electron-dense labeled bouton membrane. Scale bars = 500 nm.  
B. Quantification of labeled bouton area in both WT and dfmr150M clones. The 
dfmr1 null mutant neurons display significantly enlarged average bouton area, 
and more variable distribution of bouton sizes than wildtype (WT, n=97; dfmr50M, 
n=108, P<0.05).  
C. High magnification of a single synaptic bouton from WT (left) and dfmr150M null 
mutant (right) neurons. The null mutant boutons show a dramatically increased 
density of synaptic vesicles (SV) throughout the bouton interior and at presynaptic 
active zones (arrows). Scale bars = 100 nm.  
D. Quantification of vesicle density. Bars indicate the percentage of the total 
bouton area occupied by synaptic vesicles. (WT, n=25; dfmr150M, n=27, P < 
0.001).  
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actual vesicle accumulation in mutant boutons is much greater than is reflected in 
these numbers, because vesicles in the mutant are much more densely 
accumulated, to the extent that normally prevent clear resolution of individual 
vesicles. 
A vesicle accumulation defect of this severity has not before been reported 
in Drosophila. This defect could be due to hyperactive vesicle biogenesis, or an 
arrest in vesicular exocytosis, either resulting in increased vesicle density. Our 
previous studies have revealed synaptic vesicle accumulation only in mutants 
with severely impaired vesicular exocytosis and neurotransmitter release, such as 
syntaxin, dUNC-13 and dCAPs mutants (Aravamudan et al., 1999; Broadie, 1996; 
Renden et al., 2001). Thus, dfmr1 mutant synapses of MB neurons display 
severely aberrant ultrastructural profiles consistent with defective synaptic 
exocytosis and impaired neurotransmitter release.  
 
Discussion 
We have previously shown that dFMRP negatively regulates axonal 
branching and structural elaboration at the peripheral neuromuscular junction 
(Zhang et al., 2001). Similarly, dFMRP negatively regulates sensory dendrite 
branching and elaboration in peripheral sensory neurons (Lee et al., 2003). In 
contrast, the role of dFMRP in the central nervous system has received limited 
study, and the results have been confusing, including reports of similar 
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phenotypes in dfmr1 null mutants and following dFMRP overexpression, neuronal 
overgrowth and undergrowth in different neurons, and no phenotypes at all in 
other neurons (Dockendorff et al., 2002; Morales et al., 2002). Does dFMRP have 
a role in regulating neuronal structure in the brain? If so, does dFMRP have a 
neuron type-specific role in regulating structure? Does dFMRP truly play a 
different role in the central versus the peripheral nervous systems?  
To answer these questions, we have used the powerful MARCM clonal 
technique (Lee and Luo, 1999), to resolve the single-cell structure of dfmr1 
mutant neurons at both light and electron microscope levels. We analyzed all 
three classes of neurons in the Mushroom Body, the learning/memory center of 
Drosophila brain. Our results are in complete agreement with the previously 
reported roles of dFMRP in the larval peripheral nervous system, showing that 
dFMRP negatively regulates neuronal sprouting, branching and structural 
elaboration in the brain. We conclude, therefore, that dFMRP acts as a negative 
regulator of neuronal architecture throughout the entire nervous system; motor 
nerve terminals, sensory neuron dendrites and the cell body, dendrites and axons 
of central neurons in the brain. 
 
dFMRP negatively regulates neuronal elaboration  
The Drosophila Mushroom Body (MB) is an essential learning and memory 
center of the brain, which has been suggested to correspond functionally to the 
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hippocampus in mammals (Davis, 1993; Heisenberg, 1998; Heisenberg, 2003; 
Zars, 2000). Learning ability is strongly compromised in mutants impacting MB 
function, and lost altogether when the MB is ablated (de Belle and Heisenberg, 
1994; McBride et al., 1999). In light of the cognitive impairments of FXS patients, 
the MB is therefore the most behaviorally relevant brain region to target for study 
in the Drosophila FXS model. As with FMRP expression in mammalian neurons 
(Devys et al., 1993; Verheij et al., 1993). dFMRP is enriched in the soma of all MB 
neurons, absent from nuclei, and present at only very low levels in any processes 
(dendrites or axons). Thus, the primary role of dFMRP is likely to be in the cell 
body. In dfmr1 null mutants, we could detect only very mild defects in gross MB 
patterning. This contrasts with a recent study by Michel et al. (2004, in press) 
reporting that dfmr1 mutants display grossly compromised MB structure. We did 
not observe any such phenotypes and therefore cannot validate the result. On the 
contrary, we did observe that dFMRP overexpression led to large-scale changes 
in MB structural integrity comparable to the report of Michel et al. (2004, in press). 
Nevertheless, since the dFMRP loss-of-function situation is our primary interest, 
modeling the FXS condition, we proceeded to focus at a single-cell level of 
resolution. 
For completeness, we examined here all three neuronal classes comprising 
the MB, including γ, α’/β’ and α/β neurons, in both dfmr1 null mutants and with 
dFMRP overexpression. Loss of dFMRP causes increased structural complexity 
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throughout the entire neuron, including the extension of supernumerary 
processes from the cell body, the development of supernumerary higher-order 
branches in the dendritic arbor, overgrowth of the dendritic field, overbranching of 
axonal processes, overgrowth of axons and consequent defects in axonal 
projection. Correspondingly, overexpression of dFMRP causes simplification and 
decreased structural complexity throughout the entire neuron, including reduction 
of cell body processes, loss of dendritic branches, undergrowth of dendritic 
arbors, underbranching of axonal processes, undergrowth of axons and 
consequent defects in axonal connectivity. Thus, the level of dFMRP 
bidirectionally regulates growth and architectural elaboration throughout MB 
neurons, altering the availability of both synaptic input and output sites.  
In mammals, the only neuronal morphological defect described in either FXS 
patients or fmr1 mutant mice is longer, thinner, and structurally abnormal dendritic 
spines (Hinton et al., 1991; Irwin et al., 2002; Irwin et al., 2001; Nimchinsky et al., 
2001). This defect may be variable in different brain regions, and may also be 
developmentally transient, with potentially complete recovery in older animals 
(Nimchinsky et al., 2001). Nevertheless, reports of mammalian structural defects 
are consistent with the results reported here in Drosophila; in both cases loss of 
FMRP/dFMRP results in increased structural complexity and a consequent 
increase in the availability of synaptic sites. Thus, from flies to mammals, FMRP 
acts as a negative regulator of neuronal complexity and synaptic availability. It is 
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not currently clear whether Drosophila displays more severe mutant phenotypes 
than mammals, or whether comparable studies in mammalian systems have 
simply not been done. Perhaps the higher complexity of the mammalian brain has 
hampered the ability to sufficiently resolve single cell structure? To our knowledge, 
studies of whole neuronal structure in fmr1 mutant mice, comparable to those 
shown here in Drosophila, have not been published. Another possibility is that the 
requirement for dFMRP is indeed greater in flies, reflecting the fact that 
Drosophila has only one fmr1 gene, compared to three related genes in mammals, 
which presumably allow diversification of FMR1-dependent functions in 
mammals.  
 
dFMRP negatively regulates synapse differentiation 
MB neurons possess periodic varicosities along the length of their axons 
that represent en passé presynaptic boutons (Watts et al., 2004). In dfmr1 mutant 
neurons, the prominence of these varicosities is greatly enhanced, generating a 
distinctive “beads on a string” appearance, whereas dFMRP overexpression 
obscures these varicosities. Electron microscopy of these same neurons 
confirmed that loss of FMRP results in significantly enlarged synaptic boutons. In 
addition, bouton size is more variable, which may suggest that axons lose the 
control of bouton formation in absence of dFMRP. More strikingly, the enlarged 
mutant boutons were simply stuffed with densely accumulated synaptic vesicles. 
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Indeed, the density of synaptic vesicles in dfmr1 mutant synapses is so high that 
other features of the bouton are frequently obscured and individual vesicles often 
cannot be resolved. This ultrastructural phenotype is strongly suggestive of 
altered synaptic function, including either abnormal vesicle biogenesis or 
impaired synaptic vesicle exocytosis and consequent neurotransmitter release. 
We have previously shown that vesicle accumulation occurs in mutants blocking 
the vesicular exocytosis pathway including syntaxin, dUNC-13 and dCAPs 
mutants (Aravamudan et al., 1999; Broadie, 1996; Renden et al., 2001). In 
contrast, mutants showing vesicle accumulation as a consequence of increase 
biogenesis have not been revealed. Unfortunately, technical limitations currently 
prevent any direct investigation of synaptic function within the Drosophila MB, 
although we and others are working to overcome this restriction. Taken together, 
these studies strongly suggest that dfmr1 mutants are defective in presynaptic 
differentiation in MB neurons, likely impairing normal neurotransmitter release. 
In mammals, FMRP function has been clearly tied to synaptic mechanisms, 
although with a predominantly postsynaptic association. FMRP mRNA and 
protein are both found localized in dendritic spines in mouse brain (Antar et al., 
2004; Weiler et al., 1997), and FMRP is locally translated in an activity-dependent 
mechanism that requires activation of metabotropic glutamate receptors (Todd et 
al., 2003; Weiler and Greenough, 1999; Weiler et al., 1997). FMRP is, in turn, 
required for mGluR-dependent translation (Greenough et al., 2001; Todd et al., 
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2003). Mouse fmr1 mutants have reduced GluR1 subunits at cortical synapses, 
but not in the hippocampus or cerebellum, and, similarly, long-term potentiation 
(LTP) is reduced in the cortex but not in the hippocampus (Li et al., 2002). Huber 
et al. (2002) showed that FMRP is also required for mGluR- dependent long term 
depression (LTD) in hippocampus. Although these results suggest primarily 
postsynaptic roles for FMRP, identification of FMRP mRNA targets has conversely 
suggested mostly presynaptic functions. Among presynaptic targets identified 
have been MUNC-13, NAP-22, SEC-7 and RAB-5 (Brown et al., 2001; Miyashiro 
et al., 2003). These putative FMRP targets suggests primarily presynaptic 
functions consistent with the presynaptic defects reported here and previously 
(Zhang et al., 2001) in Drosophila. 
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Experimental Procedures 
Fly Stains and Genetics 
All flies were maintained at 25oC on standard medium. The following strains 
were generated by standard genetic methods and were used in this study: 1, 
heatshock-FLP, mouse CD8-GFP; FRT82B, tubulin P-GAL80/TM3; GAL4-OK107. 
2, y, w; FRT82B/TM3. 3, FRT82B, dfmr150M/TM6. 4, FRT82B, dfmr1dfmr3/TM6. 5, 
FRT82B, UAS-dfmr1. GAL4-OK107 was used as the driver to visualize 
mushroom body clones in all situations (Connolly et al., 1996). Mouse CD8-GFP 
was used to label the mosaic clones. All dfmr150M, dfmr1dfmr3, and UAS-dfmr1 
insertions (Zhang et al., 2001) were recombined to the FRT82B chromosome by 
classical genetic manipulation, based on the presence of FRT82B carrying the 
G418 resistance (Xu and Rubin, 1993) and PCR confirmation of all the genetic 
elements. 
 
Immunohistochemistry 
The following antibodies were used in this work: rat anti-mouse CD8a, 1:100 
(Caltag); mouse anti-Drosophila Fasciclin II 1D4, 1:10 (Developmental Studies 
Hybridoma Bank); mouse anti-dFMRP, 1:1000 (Developmental Studies 
Hybridoma Bank); FITC-conjugated goat anti-rat IgG, 1:100 (Jackson); goat 
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Cy3-conjugated goat anti-mouse IgG, 1:100 (Jackson); rat anti-Drosophila DLG, 
1:100 (V. Budnik). All fluorescent images were collected using a ZEISS LSM 510 
META Laser Scanning Microscope and image-collection software. All image 
processing were done with Adobe Photoshop 7.0. 
 
Mosaic analysis with a repressible cell maker (MARCM) 
The MARCM technique was employed as described in Lee and Luo (1999). 
To generate MARCM clones in γ-neuron, embryos were collected within 5 hours 
window and cultured at 25 oC. 20 hours old embryos were heat-shocked at 37 oC 
for 1 hour.  To generate α’/β’ and α/β MARCM clones, the same heat-shock was 
done to 5 day old larvae and 8 day old pupa, respectively. Adult brains were 
dissected out from whole fly heads. All brains were from 3 days to 15 days adults 
after eclosion. Brains were dissected in 1XPBS, fixed in 4% paraformaldehyde 30 
minutes, and processed with immuno-staining.  
 
Morphological Quantification 
 All quantification data were come from single-cell MARCM clones. For 
γ-neuron axonal quantification, the primary axon branch was identified first and all 
other processes extended from this main trunk were counted as branches. The 
length of each branch was measured based on the 3D images obtained from 
confocal microscopy. All branch lengths of single axon branches were added 
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together to get the total cumulative length. For α’/β’-neuron cell body process 
quantification, all processes except the main process were counted. One branch 
was counted as one process. In mutants, branch numbers >10 (always difficult to 
tell apart) were counted as 10.  
 
Electron Microscopy 
Ultrastructural analyses of Drosophila brains were done using standard 
protocols (Barth et al., 1997; Yasuyama et al., 2002). Briefly, 1-3 days old adult 
brains with MB MARCM clones were dissected in 1XPBS buffer and immediately 
fixed for 30 minutes in 2% paraformaldehyde. The samples were subsequently 
rinsed with PBS-BSA buffer 3 hours in 4 ºC, stained with rat anti-mouse CD8 
antibody (1:100) 12 hours in 4 ºC, washed with PBS-Horse serum buffer 3 hours 
in 4ºC , stained with biotinylated anti-rat IgG (1:50) 12 hours in 4 ºC, and washed 
in 1XPBS in 4ºC overnight. Brains were sequentially treated with Vectastain ABC 
kit (vector laboratories, Inc. Burlingame, CA), rinsed with in 1×PBS 1 hours in 
room temperature, stained with Vector peroxidase substrate DAB kit, and washed 
with PBS for 3 hours at 4ºC, and incubated in 1% glutemaldehyde 4ºC overnight. 
Samples were prepared for transmission electron microscopy (TEM) using 
standard techniques(Featherstone et al., 2001), with minor modifications. Briefly, 
samples were transferred to 2% glutaraldehyde for 45 minutes (2% 
glutaraldehyde in 0.2M phosphate buffer). Specimens were washed in phosphate 
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buffered sucrose 0.2M, transferred to 1% osmium tetroxide in ddH2O for 1 hr, 
washed again in ddH2O, and stained en bloc in 2% aqueous uranyl acetate for 1 
hr, and washed in ddH2O. Brains were dehydrated through an increasing series of 
ethanol (30%-100%), passed through propylene oxide for 20 minutes, and 
transferred to 50% / 50% propylene oxide and araldite for 30 minutes. Samples 
were placed in pure araldite for 30 minutes, under vacuum (-25psi). Finally 
specimens were transferred into fresh araldite overnight. Blocks were trimmed as 
close to the darkly stained mushroom bodies as possible. Ribbons of thin (~55 
nm) sections were obtained using a Leica Ultracut UCT 54 Ultramicrotome and 
examined on a Phillips CM 12 TEM.   
 
Ultrastructural Quantification 
To assay bouton area, 25000X images were used to compare wild type and 
dfmr1 mutant MARCM Mushroom Body clones. Areas were measured using NIH 
ImageJ software. To assay synaptic vesicle density, 25000X images were used. 
In dfmr1 mutant MARCM Mushroom Body clones, 2 micron circles were centered 
over the labeled cell, and assays made of labeled bouton (dfmr1 homozygous 
mutant) and unlabeled boutons (control) in a nearest neighbor comparison. Total 
bouton area and synaptic vesicle occupied bouton area were measured with NIH 
ImageJ software. The percentage of vesicle area was calculated by dividing 
vesicle area by total bouton area, giving the % vesicle area. 
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Summary 
A current hypothesis proposes that Fragile X Mental Retardation Protein 
(FMRP), an RNA-binding translational regulator, acts downstream of 
glutamatergic transmission, via metabotropic glutamate receptor (mGluR) 
Gq-dependent signaling, to modulate protein synthesis critical for trafficking 
ionotropic glutamate receptors (iGluRs) at synapses. However, direct evidence 
linking FMRP and mGluR function with iGluR synaptic expression is limited. In this 
study, we use the Drosophila Fragile X model to test this hypothesis at the 
well-characterized glutamatergic neuromuscular junction (NMJ). Two iGluR 
classes reside at this synapse, each containing common GluRIIC (III), IID and IIE 
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subunits, and variable GluRIIA (A-class) or GluRIIB (B-class) subunits. In dfmr1 
null mutants, A-class GluRs accumulate and B-class GluRs are lost, whereas total 
GluR levels do not change, resulting in a striking change in GluR subclass ratio at 
individual synapses. The sole Drosophila mGluR, DmGluRA, is also expressed at 
the NMJ. In dmGluRA null mutants, both iGluR classes increase, resulting in an 
increase in total synaptic GluR content at individual synapses. Targeted 
postsynaptic dmGluRA over-expression causes the exact opposite GluR 
phenotype to the dfmr1 null, confirming postsynaptic GluR subtype-specific 
regulation. In dfmr1; dmGluRA double null mutants, there is an additive increase 
in A-class GluRs, and a similar additive impact on B-class GluRs, towards normal 
levels in the double mutants. These results show that both dFMRP and DmGluRA 
differentially regulate the abundance of different GluR subclasses in a convergent 
mechanism within individual postsynaptic domains. 
 
Introduction 
Fragile X Syndrome (FXS) is the leading known genetic cause of both 
mental retardation and autism spectrum disorders. The disease also produces 
hyperactivity, hypersensitivity to sensory stimuli and epileptic seizures (O'Donnell 
and Warren, 2002; Bagni and Greenough, 2005; Garber et al., 2006). FXS is 
caused by silencing of the fragile X mental retardation 1 (fmr1) gene, which 
encodes the RNA-binding, translational regulator Fragile X Mental Retardation 
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Protein (FMRP) (Jin and Warren, 2000; Brown et al., 2001; Li et al., 2001). In fmr1 
knockout mice, hippocampal long-term depression (LTD) dependent upon 
activation of the group I class 5 metabotropic glutamate receptor (mGluR) is 
selectively enhanced (Huber et al., 2002; Koekkoek et al., 2005). This LTD is 
caused by loss of surface AMPA GluRs, a mechanism requiring protein synthesis 
(Huber et al., 2000; Huber et al., 2001; Nosyreva and Huber, 2006; Pfeiffer and 
Huber, 2006). Similarly, cerebral cortex long-term potentiation (LTP) is reduced 
concomitant with reduced GluR1 expression (Li et al., 2002; Larson et al., 2005; 
Zhao et al., 2005). Two major FXS phenotypes in fmr1 knockout mice, reduced 
habituation in open field tests and increased sensitivity to audiogenic seizures, 
can be rescued by the mGluR5 antagonist MPEP (Yan et al., 2005).   
In a negative feedback loop, FMRP suppresses its own translation in 
postsynaptic terminals, in a mechanism regulated by group I mGluRs, whose 
activation is a potent stimulus for synaptic protein synthesis (Weiler et al., 1997; 
Todd et al., 2003b; Weiler et al., 2004). Both FMRP synaptic localization and 
expression are increased by glutamatergic activity, and this regulation is blocked 
by MPEP (mGluR5 antagonist) and increased by DHPG (agonist) (Weiler et al., 
1997; Antar et al., 2004; Weiler et al., 2004; Hou et al., 2006). mGluR5-dependent 
LTD is normally completely dependent on new translation, but in the absence of 
FMRP, mGluR5 activation does not trigger protein synthesis (Weiler et al., 2004; 
Aschrafi et al., 2005). The anisomycin (translation inhibitor) response is lost and 
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the DHPG-induced increase of synaptic proteins synthesis is reduced in fmr1 KO 
mice (Hou et al., 2006; Nosyreva and Huber, 2006). A primary target of mGluR5 
activation is to regulate trafficking of AMPA GluRs (Carroll et al., 1999; Snyder et 
al., 2001; Xiao et al., 2001; Nosyreva and Huber, 2005). These data suggest a 
mechanistic connection between mGluR signaling, the translation regulatory 
function of FMRP, and AMPA GluR expression: a hypothesis termed “the mGluR 
theory of FXS” (Bear et al., 2004). 
We developed a Drosophila FXS model through mutation and 
over-expression of Drosophila fmr1 (dfmr1) (Zhang et al., 2001; Pan et al., 2004; 
Zhang and Broadie, 2005).  In support of the mGluR theory, feeding dfmr1 
mutants with MPEP, as well as class II/III mGluR antagonists, can rescue some 
mutant phenotypes, including behavioral (courtship learning and memory) and 
morphological (mushroom body structure) defects (McBride et al., 2005). A great 
advantage for testing the mGluR theory in Drosophila is that the genome encodes 
only a single mGluR, DmGluRA (Parmentier et al., 1996; Bogdanik et al., 2004; 
Mitri et al., 2004). We characterized DmGluRA to show it is synaptically localized 
and regulates synaptic structure and activity-dependent function at the 
neuromuscular junction (NMJ) (Bogdanik et al., 2004). This glutamatergic NMJ 
contains five AMPA-like GluR subunits, GluRIIA-E. Three subunits (GluRIIC, IID 
and IIE) are essential for all GluRs, whereas the other two subunits define two 
GluR classes; A-class (GluRIIA) and B-class (GluRIIB), which are differentially 
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regulated, subsynaptically localized, and possess distinct functional properties, 
including differential conductance and opening kinetics (Schuster et al., 1991; 
Petersen et al., 1997; DiAntonio et al., 1999; Sigrist et al., 2002; Marrus et al., 
2004; Featherstone et al., 2005; Qin et al., 2005b).  
The purpose of this study was to genetically test the mGluR theory of FXS in 
the Drosophila model; specifically mechanistic links between dFMRP, DmGluRA 
and ionotropic GluR expression. In dfmr1 null mutants, A-class GluRs accumulate 
and B-class GluRs are lost, significantly altering the GluR class ratio in single 
synapses. In dmGluRA null mutants, both GluR classes increase, showing that 
the metabotropic receptor negatively regulates both ionotropic receptors. 
Targeted rescue experiments demonstrate that dfmr1 defects are due to a 
postsynaptic requirement. Postsynaptic over-expression of DmGluRA causes the 
exact opposite GluR class-specific changes to the dfmr1 null. In dfmr1; dmGluRA 
double null mutants, there are additive effects on both GluR classes. These 
results show that DmGluRA glutamatergic signaling and dFMRP regulatory 
function converge to control the GluR class ratio in the postsynaptic domain, but 
that the two pathways are at least partially independent.  
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Results 
 
dFMRP differentially regulates GluR classes  
Subunit-specific antibodies were used to examine three GluR populations at 
the NMJ; A-class receptors only (anti-GluRIIA), B-class receptors only 
(anti-GluRIIB) and the total GluR population (anti-GluRIIC) (Yoshihara and 
Littleton, 2002; Marrus et al., 2004; Liebl et al., 2005; Qin et al., 2005a). 
Fluorescence intensity was compared to an internal fluorescent signal marking 
the NMJ synaptic terminal: anti-HRP labels a carbohydrate epitope in the 
neuronal membrane of NMJ boutons (Katz et al., 1988; Wang et al., 1994; Sun 
and Salvaterra, 1995). The dfmr1 null and w1118 genetic background control (WT) 
animals were processed simultaneously and imaged using identical microscope 
settings. All quantification was done on type IB synaptic boutons in the muscle 4 
NMJ in segment A3. Fluorescence intensity was calculated at each NMJ terminal 
and then averaged between the two A3 hemisegments to generate each data 
point for each genotype. Representative images and quantification results are 
shown in Figure 3.1.  
Synaptic A-class GluRs were very significantly increased in dfmr1 null 
mutants compared to matched controls (Figure 3.1A). Average fluorescence 
intensity in NMJ synaptic boutons was increased by 30% in mutant terminals 
relative to controls (WT, 96.3±5.03; dfmr1, 124.62±4.84; N=15 for each genotype;  
  
 
 
 
 
Figure 3.1: dFMRP differentially regulates A- and B-class GluRs 
Third instar NMJs were probed using subunit-specific anti-GluRs (green: IIA, IIB, 
IIC) and anti-HRP (red) antibodies. The HRP antibody recognized a neural 
membrane epitope, and thus labels the NMJ synapse and acts as an internal 
fluorescence control for intensity quantification. Type IB boutons on muscle 4 in 
abdominal segment A3 were used for all quantified analysis.  
A-C. Representative images of GluRIIA, IIB and IIC expression in WT (w1118) and 
dfmr1 null mutant (dfmr150m).  
D-F. Fluorescence intensity quantification of all three GluR subunits and the HRP 
internal standard.  
D. The GluRIIA subunit expression is significantly increased in dfmr1 mutants. 
(N=15 for both WT and dfmr1).  
E. The GluRIIB subunit expression is significantly decreased in dfmr1 mutants. 
(N=10 for both WT and dfmr1).  
F) The GluRIIC subunit expression is comparable in WT and dfmr1 mutants. 
(N=10 for both WT and dfmr1).  
0.0001<P<0.001(**); P<0.0001(***). 
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P<0.0001; Figure 3.1D). There was no difference in HRP fluorescent intensities 
between mutants and controls (Figure 3.1D). In contrast, B-class GluRs were very 
significantly decreased in dfmr1 null mutants compared to matched controls 
(Figure 1B).  GluRIIB levels were decreased to a similar level (23%) in dfmr1 null 
terminals relative to controls (WT, 129.3±5.67; dfmr1, 99.62±3.81; N=10 for each 
genotype; P=0.0004; Figure 1E). There was no difference in HRP fluorescent 
intensities between mutants and controls (Figure 1E). Total GluR content at the 
same synaptic terminals was assayed using an antibody against the common 
GluRIIC subunit (Figure 1C). Since the two GluR classes displayed similar 
opposing abundance changes, as might be predicted there was no significant 
difference in total GluR abundance between dfmr1 and control synapses (WT, 
108.94±2.95; dfmr1, 105.34±7.83; N=10 for each genotype; P=0.76; Figure 1F). 
These data show that the two GluR classes are differentially modulated in 
opposite directions in the absence of dFMRP function, with A-class GluRs 
increasing, B-class GluRs decreasing, but total GluR levels remaining normal. 
 
All GluR classes decreased by dfmr1 over-expression in postsynaptic 
muscle 
Neuronal over-expression of the dFMRP protein results in synaptic structural 
and functional defects that are largely the inverse of dfmr1 null mutant phenotypes, 
in both the NMJ and in the central nervous system (Zhang et al., 2001; Pan et al., 
2004). However, roles of dFMRP in the postsynaptic muscle have not been 
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investigated. To begin to assay whether GluR phenotypes in dfmr1 null mutants 
arise through postsynaptic dysfunction, as predicted, and to determine whether 
GluR phenotypes are also inversely correlated in loss and gain of function 
conditions, GluR levels were next quantified in dFMRP over-expression (OE) 
mutants. The UAS-dfmr1 transgenic line was crossed with neuronal specific 
(ELAV-Gal4) and muscle specific (MHC-Gal4) drivers to induce dFMRP 
over-expression in either presynaptic (in neuron, NOE) or postsynaptic (in muscle, 
MOE) compartments (Figure 3.2). As above, fluorescence intensities for all three 
GluR populations were compared relative to the internal HRP fluorescence control. 
Over-expression of dfmr1 in the muscle had no significant impact on the 
presynaptic HRP fluorescence in any of these experiments. 
As predicted, dFMRP acts in the postsynaptic muscle to regulate the 
postsynaptic expression of A-class GluRs, and there is an inverse relationship 
between the increase observed in the dfmr1 null (Figure 3.1A, D) and the 
decrease caused by dfmr1 muscle over-expression (MOE) in the postsynaptic 
cells (Figure 3.2A, D). GluRIIA levels were decreased 15% compared to controls, 
a highly significant (P=0.0008) reduction. Further as expected, neural 
over-expression (NOE) of dfmr1 in the presynaptic compartment caused no 
change in the abundance of the postsynaptic A-class GluRs (Figure 3.2A, D). In 
contrast, the situation with the B-class GluRs was more complex. 
Over-expression of dfmr1 in the muscle caused a 27% decrease in GluRIIB  
  
 
 
 
 
Figure 3.2: Total GluR abundance is decreased by dfmr1 over-expression in 
muscle 
Third instar NMJs were probed using subunit-specific anti-GluRs (green) and 
anti-HRP (red) antibodies. Type IB boutons on muscle 4 in A3 were used for all 
imaging analysis.  
A-C. Representative images of GluRIIA, IIB and IIC expression in dFMRP muscle 
over-expression (MOE) and neuronal over-expression (NOE).  
D-F. Fluorescence intensity quantification for each GluR subunit.  
D. GluRIIA is decreased in dfmr1 MOE mutants, but unchanged in dfmr1 NOE 
mutants (N=11 for all genotypes).  
E. GluRIIB is decreased in both dfmr1 MOE and NOE mutants (N=13 for all 
genotypes).  
F. The GluRIIC subunit is decreased in dfmr1 MOE mutants, but not changed in 
dmfr1 NOE mutants (N=10 for all genotypes).  
0.0001<P<0.001(**); P<0.0001(***). 
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expression (Figure 3.2B, E), which resembled the decrease observed in the dfmr1 
null synapses (Figure 3.1B, E). Moreover, presynaptic dfmr1 over-expression also 
caused a smaller (15%), but still significant (P=0.008), decrease in GluRIIB 
expression (Figure 3.2B, E). The change in the total GluR population was largely 
consistent with the combined changes of the two subclasses. The total GluR level 
also significantly (P<0.01) decreased by over-expression of dfmr1 in the muscle 
(Figure 3.2C, F). Neural over-expression of dfmr1 in the presynaptic terminal had 
no distinguishable impact on total GluR abundance in the postsynaptic domain 
(Figure 3.2C, F). These data support a primary role for dFMRP within the 
postsynaptic cell regulating the postsynaptic abundance of GluRs, but also show 
that presynaptic dFMRP levels can impact postsynaptic GluRIIB. 
 
All ionotropic GluRs increase in the absence of metabotropic GluR 
signaling 
Mammals possess three types of metabotropic GluRs (mGluRs) and eight 
specific mGluR classes. Activation of different mGluR classes differentially 
regulates synaptic AMPA GluR expression (Snyder et al., 2001; Nosyreva and 
Huber, 2005). Recently, mounting evidence has suggested a connection between 
type I mGluR (mGluR5) activation and the translational regulatory function of 
FMRP to promote down-regulation of synaptic AMPA GluR1 (Hou et al., 2006; 
Nosyreva and Huber, 2006). The situation in Drosophila is much simpler. The 
Drosophila genome encodes only a single mGluR, DmGluRA. We previously 
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showed that this receptor is localized to the glutamatergic NMJ and that dmGluRA 
null mutants display strikingly elevated short-term synaptic facilitation and 
augmentation (Bogdanik et al., 2004). In that earlier work, we identified a 
P-element deletion excision line, 112b, as a null mutant (hereafter called 
dmGluRA) and a companion precise excision line, 2b, as a genetic background 
control. Here, these lines were used to investigate the role of mGluR signaling in 
the regulation of ionotropic GluR abundance in the NMJ synaptic terminal. 
The three different GluR populations were examined in the dmGluRA null 
mutant compared to its 2b genetic background control (Figure 3.3). All three 
tested GluR subunits were significantly increased in dmGluRA mutants: GluRIIA 
was increased 15% (WT, 107.5±4.2; dmGluRA, 123.5±3.2; N=13 for each 
genotype; P=0.006; Figure 3.3A, D), GluRIIB was increased 11% (WT, 
98.21±3.24; dmGluRA, 109.12±3.27; N=16 for each genotype; P=0.03; Figure 
3.3B, E) and GluRIIC was increased 15% (WT, 109.08±4.38; dmGluRA, 
124.7±3.42; N=13 for each genotype; P=0.0096; Figure 3.3C, F). The HRP 
internal fluorescence standard displayed no change between the dmGluRA null 
and the 2b genetic background control in any of the experimental trials (Figure 
3.3). These data show that loss of all mGluR signaling results in the upregulation 
of total ionotropic GluR abundance in the postsynaptic domain, and that A- and 
B-class GluRs are similarly suppressed by DmGluRA glutamatergic signaling. 
  
 
 
 
 
 
Figure 3.3: Total GluR abundance is increased in the absence of mGluR 
signaling 
Third instar NMJs were probed using subunit-specific anti-GluRs (green) and 
anti-HRP (red) antibodies. Type IB boutons on muscle 4 in A3 were used for all 
imaging analysis.  
A-C. Representative images of GluRIIA, IIB and IIC expression in WT (2b, 
p-element precise excision line) and dmGluRA null mutant (dmGluRA112b, 
imprecise deletion line).  
D-F. Fluorescence intensity quantification of all three GluR subunits and the HRP 
internal standard. All three tested GluR subunits (GluRIIA, GluRIIB, and GluRIIC) 
were increased in dmGluRA mutants, while HRP showed no significant change in 
any trial (N=13 for both genotypes in GluRIIA and GluRIIC tests, N=16 for both 
genotypes in GluRIIB test).   
0.001<P<0.05(*); 0.0001<P<0.001(**). 
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Postsynaptic DmGluRA over-expression induces GluR class-specific 
changes  
To determine whether the regulatory function of DmGluRA on ionotropic 
GluRs reflects pre- or postsynaptic signaling, GluR levels were next examined in 
targeted DmGluRA over-expression (OE) mutants. As above, the 
UAS-DmGluRA transgenic line (Bogdanik et al., 2004) was driven by neural 
ELAV-Gal4 or muscle MHC-Gal4 to induce DmGluRA over-expression in either 
presynaptic (NOE) or postsynaptic (MOE) cells. The results are displayed in 
Figure 3.4.  
Postsynaptic over-expression of DmGluRA changes GluR class abundance 
in exactly the opposite direction of the dfmr1 null; A-class GluRs are decreased 
and B-class GluRs are increased (compare Figures. 3.1 and 3.4).  GluRIIA 
expression was decreased 10% in DmGluRA muscle over-expression (Figure 
3.4A, C; N=15, P=0.003), and GluRIIB was similarly increased by 10% (Figure 
3.4B, D; N=12, P=0.05). As in the dfmr1 null with opposing GluR class changes, 
there are no change in total GluR based on the common GluRIIC subunit. In 
addition, however, presynaptic over-expression of DmGluRA down-regulates 
both A- and B-class GluRs, which is an opposite phenotype to the dmGluRA null 
(compare Figs. 3 and 4). The expression of GluRIIA was decreased 10% (Figure 
3.4A, C; N=15, P=0.015), and GluRIIB was decreased 20% (Figure 3.4B, D; 
N=12; P=0.006). These data show that presynaptic DmGluRA function indirectly 
  
 
 
 
 
 
Figure 3.4: DmGluRA postsynaptic over-expression causes the opposite 
GluR class changes to the dfmr1 null.  
NMJs probed using subunit-specific anti-GluRs (green) and anti-HRP (red) 
antibodies. Type IB boutons on muscle 4 in A3 were used for all imaging analysis. 
Representative images of GluRIIA (A) and GluRIIB (B) with DmGluRA muscle 
over-expression (MOE) and neuronal over-expression (NOE).  
C, D. Fluorescence intensity quantification for each GluR class.  
C. GluRIIA is decreased with both DmGluRA MOE and NOE (N=15 for all 
genotypes).  
D. GluRIIB is increased with MOE but decreased with NOE mutants (N=12 for all 
genotypes).  
0.001<P<0.05(*). 
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Indirectly regulates postsynaptic GluR abundance, presumably via a homeostatic 
mechanism (Paradis et al., 2001; Fong et al., 2002; Wierenga et al., 2005).  
 
dFMRP regulates the ratio of A- to B-class GluRs in single postsynaptic 
domains 
We next queried where dFMRP and DmGluRA regulate A- and B-class within 
individual synaptic boutons. The two GluR classes exhibit largely overlapping 
expression patterns in distinct postsynaptic membrane domains directly apposing 
presynaptic active zones (Figure 3.5). There are approximately 20 of these 
punctate GluR postsynaptic domains within each type IB NMJ bouton. It has been 
reported, however, that the two GluR classes can also spatially segregate in 
non-overlapping puncta in a minority of cases (Marrus et al., 2004). By staining for 
the two class-specific subunits simultaneously, the distribution and fluorescence 
intensities of A- and B-class GluRs were directly compared in both dfmr1 and 
dmGluRA mutants (Figure 3.5).  
As might be predicted, the GluRIIA/GluRIIB ratio at individual synaptic 
boutons is dramatically altered by the absence of dFMRP. The IIA/IIB ratio is 
roughly equal in control synapses (1.07±0.03), with the two GluR subclasses 
showing a similar distribution in the punctate postsynaptic domains (Figure 3.5A). 
In quite evident contrast, the dfmr1 null mutant displayed a coincident strong 
elevation in GluRIIA and downregulation in GluRIIB, dramatically altering the 
GluR presentation within single synaptic boutons and in individual postsynaptic 
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punctate domains (Figure 3.5B). As a result, the IIA/IIB ratio was strongly shifted 
towards the A-class receptor (1.53±0.08; P<0.0001; N=9 for each genotype; 
Figure 3.5C). Comparing highly magnified images of dfmr1 null and control 
boutons, there was no detectable shift in the distribution pattern of the two GluR 
classes. Specifically, there was no evidence of the appearance/disappearance of 
new postsynaptic puncta, or a differential change in the ratio of IIA/IIB within 
subclasses of postsynaptic puncta (Figure 3.5). Therefore, the strongly skewed 
IIA/IIB receptor ratio represents an increase of A-class GluR and decrease of 
B-class GluR within the same postsynaptic receptor domains in the absence of 
dFMRP function.  
The IIA/IIB ratio was similarly examined in the dmGluRA null mutants. As 
might be predicted, there was no apparent difference between the WT (2b) control 
and dmGluRA, with the mutant showing a coincident increase in both A- and 
B-class GluRs without apparent change in ratio or distribution (data not shown). 
Quantification of the IIA/IIB receptor ratio showed no significant change between 
the mutant and control (P=0.14; N=11 for each genotype; Figure 3.5D). These 
results show that DmGluRA signaling negatively regulates A- and B-class GluRs 
in common within single synaptic boutons, whereas dFMRP bidirectionally 
regulates the two receptor classes to determine the IIA/IIB expression ratio within 
single postsynaptic punctate domains.  
  
 
 
 
 
Figure 3.5: Ratio of A- to B-class GluRs is dramatically changed in dfmr1 
mutants 
Third instar NMJs were probed using subunit-specific anti-GluRIIA (green), 
anti-GluRIIB (red), and anti-HRP (purple) antibodies. Type IB boutons on muscle 
4 in A3 were used for all imaging analysis.   
A, B. Representative images of WT (w1118) and dfmr1 mutant NMJs at a high 
magnification showing individual punctate GluR postsynaptic domains. GluRIIA is 
highly increased and GluRIIB is highly decreased within overlapping punctate 
domains in dfmr1 mutants. There was no detectable spatial shift in GluR classes 
relative to each other in dfmr1 mutants compared to control.  
C, D. Fluorescence intensity ratio of GluRIIA to GluRIIB.  
C. IIA/IIB ratio is 50% increased in dfmr1 compared to control (N=9 for both 
genotypes).  
D. IIA/IIB ratio is shows no significant change in dmGluRA mutants (WT=2b; 
N=11 for both genotypes).  
P<0.0001(***). 
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The postsynaptic regulatory function of dFMRP  
Transynaptic signaling strongly modifies synapse assembly at the 
Drosophila NMJ. The level of glutamate release from presynaptic terminals can 
alter the abundance of postsynaptic GluRs (Featherstone et al., 2002; Chen and 
Featherstone, 2005) and, conversely, GluR over-expression can feedback to alter 
active zone assembly and function (Sigrist et al., 2002). Since dFMRP function is 
known to regulate presynaptic glutamate release (Zhang et al., 2001) and 
increase postsynaptic A-class GluR abundance (Figure 3.1), it is critical to 
examine possible transynaptic mechanisms for these changes. To further 
determine whether dFMRP regulates GluRs by pre- or postsynaptic mechanisms, 
two experiments were performed to examine presynaptic consequences of 
dFMRP loss.  
Presynaptic active zones were assayed with a probe for NC82/bruchpilot, an 
ELKS/CAST protein at the active zone (Figure 3.6; (Kittel et al., 2006; Wagh et al., 
2006). Each NC82-positive punctum was counted as one active zone within a 
synaptic bouton area, which was defined by presynaptic membrane HRP staining. 
Compared to control, dfmr1 null mutants display significantly more active zones 
per bouton (WT=18.8±0.75; N=164; dfmr1=23.1±1.2; N=152; P=0.003; Figure 
3.6A, C). However, dfmr1 mutants possess significantly larger synaptic boutons 
than controls (WT=6±0.25; N=164; dfmr1=7.7±0.46; N=152; P=0.0009). When 
active zone density is considered (number pre area, μm2), there was no difference 
  
 
 
 
 
 
 
Figure 3.6: Presynaptic active zone density normal in dfmr1 and dmGluRA 
mutants 
Third instar NMJs probed using anti-NC82 (green), and anti-HRP (red) antibodies. 
Type IB boutons on muscle 4 in A3 were used for all imaging analysis. Bouton 
area was defined by the boundary of HRP staining. A) Representative images of 
WT (w1118) and dfmr1 mutant. B) Representative images of WT (2b) and 
dmGluRA (112b) mutant. C, D) Quantification of both the number of active zones 
per bouton and the active zone density per area (μm2). C) The active zone 
number per bouton is increased in dfmr1 mutants, but there is no difference in 
active zone density. D) Both active zone number and density are not changed in 
dmGluRA mutants. 0.001<P<0.05(*). 
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in dfmr1 mutants, which had identical density to controls (WT=3.2±0.04, N=152; 
dfmr1=3.2±0.06,N=164; P=0.73). In dmGluRA mutants, there was no change in 
either active zone number or density (Figure3.6B,D; N=103 WT; N=114 dmGluRA). 
Note that in all GluR measurements, fluorescent density per synaptic area was 
assayed, and therefore the changes in GluR class abundance occur over an area 
in which active zone density was unchanged. 
To directly test a possible presynaptic dFMRP role, targeted presynaptic 
dFMRP expression was driven in the dfmr1 null to assess the impact on the GluR 
phenotypes. The neural ELAV-Gal4 driver was crossed into the dfmr1 null 
background with a recombinant line of UAS-dfmr1. This combination strongly 
expressed dFMRP in the presynaptic neurons, whereas dFMRP was 
undetectable in the postsynaptic muscles (data not shown). The two controls were 
ELAV-GAL4 in the heterozygous background (+/dfmr1), and the dfmr1 null (null in 
both pre- and postsynaptic cells). The presynaptic-only expression of dFMRP 
failed to rescue either GluRIIA or GluRIIB phenotypes (Figure 3.7). The A-class 
GluRs were increased in this single-side rescue (+/dfmr1=118±4.88; 
dfmr1=130.8±4.56; presynaptic rescue=139.5±3.87; N=9 for all genotypes; 
P=0.002 between +/dfmr1 and presynaptic rescue; Figure 3.7A, C). The B-class 
GluRs were decreased in single-side rescue (+/dfmr1=134.63±3.65; 
dfmr1=124.16±5; presynaptic rescue=112.56±3.58; N=10 for all genotypes; 
P=0.004 between +/dfmr1 and presynaptic rescue; Figure 3.7B, D). No significant  
  
 
 
 
 
 
Figure 3.7: Targeted presynaptic dFMRP expression in dfmr1 null mutants 
Third instar NMJs probed using subunit-specific anti-GluRs (green) and anti-HRP 
(red) antibodies. Type IB boutons on muscle 4 in A3 were used for all imaging 
analysis. Representative images of GluRIIA (A) and GluRIIB (B) in heterozygous 
mutant (+/dfmr1), dfmr1 null, and presynaptic-only rescue of dFMRP expression.  
C, D. Fluorescence intensity quantification of each GluR subunit and the HRP 
internal standard.  
C. GluRIIA is significantly increased in dfmr1 mutants, and is not rescued by 
presynaptic expression of dFMRP (N=9 for all genotypes).  
D. GluRIIB is significantly decreased in dfmr1 mutants, and is not rescued by 
presynaptic expression of dFMRP (N=10 for all genotypes).  
0.001<P<0.05(*); 0.0001<P<0.001(**). 
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changes were detected on GluRIIC levels in either dfmr1 null and presynaptic 
rescue conditions (data not shown).  
 
DmGluRA and dFMRP functions converge to regulate synaptic GluR 
expression 
The above results demonstrate that both dFMRP and DmGluRA function to 
regulate GluR abundance in the postsynaptic compartment. Loss of function of 
these two genes increases A-class GluRs, whereas B-class GluRs are down- 
regulated in the absence of dFMRP and upregulated in the absence of DmGluRA. 
The best possible test for interactions between these two proteins is to generate 
double null mutants, in order to determine whether GluR phenotypes may cancel 
out, be additive, or show a synergistic interaction. If the two proteins function in 
the same signaling pathway, the prediction is that an epistatic interaction will be 
observed, with the downstream function epistatic to the upstream function. In this 
case, dFMRP translation regulation function is clearly predicted to be downstream 
of DmGluRA glutamatergic signaling. If the two proteins act in pathways that 
converge on GluR regulation, then mutant phenotypes are predicted to be 
additive, without any epistasis. To test these two possibilities, we generated a 
dfmr1; dmGluRA double null mutant. We crossed dfmr1 into both the 2b 
(dmGluRA background control) and dmGluRA null mutant backgrounds. There 
was no significant difference between the original single dfmr1 and dfmr1; 2b in 
  
 
 
 
Figure 3.8: GluR expression in dfmr1; dmGluRA double null mutants  
Third instar NMJs were probed using subunit-specific anti-GluRs (green) and 
anti-HRP (red) antibodies. Type IB boutons on muscle 4 in A3 were used for all 
imaging analysis.  
A-C. Representative images of GluRIIA, IIB and IIC expression in WT (2b), 
dfmr1;2b single mutants, and dfmr1;dmGluRA double mutant NMJs. D-F) 
Fluorescence intensity quantification of each GluR subunit and the HRP internal 
standard in independent trials.  
D. GluRIIA is significantly increased in dfmr1 single mutants and the dfmr1; 
dmGluRA double mutants display an additive, highly significant level of GluRIIA 
expression (N=27 for dfmr1;2b and dfmr1;dmGluRA).  
E. GluRIIB is very significantly decreased in dfmr1 single mutants, and the dfmr1; 
dmGluRA double mutants display a reduced, less significant change in GluRIIB 
expression, indicating an additive interaction (N=18 for dfmr1;2b and 
dfmr1,dmGluRA).  
F. GluRIIC showed no significant change in dfmr1 single or dfmr1; dmGluRA 
double mutants (N=13 for dfmr1;2b and dfmr1,dmGluRA). In all independent trials, 
there was no significant change of HRP levels among the three genotypes. 
0.001<P<0.05(*); 0.0001<P<0.001(**). 
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any assays (data not shown), therefore genetic background is not a complicating 
factor. All three GluR populations were assayed in all mutant combinations (Figure 
3.8).  
For both GluR classes, the dfmr1; dmGluRA double null mutant showed the 
additive phenotypes of dfmr1 and dmGluRA single null mutants. For GluRIIA, the 
dfmr1; 2b single mutant displayed a significant increase and the double mutant 
displayed a significantly larger, further elevation in A-class receptor expression 
(dfmr1; dmGluRA, 114.24±3.24; N=27; P=0.004; Figure 3.8A, D). For GluRIIB, the 
dfmr1; dmGluRA double mutant similarly showed an additive phenotype. The 
dfmr1 single mutant displayed a 20% decrease in GluRIIB level compared to WT 
(2b) controls (dfmr1; 2b, 91.92±23.16; WT (2b), 112.29±3.32; N=18, P=0.0007; 
Figure 3.8B, E). However, the dmGluRA single mutant displayed an apposing 
11% increase in GluRIIB (see Figure 3.3B, E). The dfmr1; dmGluRA double 
mutant displayed an intermediate, additive phenotype, with a 12% increase in 
B-class GluRs relative to the dfmr1 single mutant (dfmr1; 2b, 91.92±23.16; 
dfmr1;DmGluRA, 102.74±2.88; N=18 for both, P=0.016; Figure 3.8B, E). Thus, 
the double mutant displayed only an 8% decrease in GluRIIB compared to the 
control, a significant difference (P=0.05) compared to the dfmr1 single mutant. For 
GluRIIC, there were no significant changes between any of the genotypes (WT 
(2b), 109.03±5.67, N=8; dfmr1; 2b, 114.54±4.46; dfmr1; dmGluRA, 118.93±4.11; 
N=13 for both mutants; P=0.48 between WT and dfmr1; P=0.45 between dfmr1 
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and dfmr1; dmGluRA; Figure 3.8C, F). Similarly, the ratio of GluRIIA/GluRIIB 
subunits in dfmr1; 2b single mutants and dfmr1; dmGluRA double mutants was 
not significantly different (dfmr1; 2b, 1.51±0.05; dfmr1; dmGluRA, 1.42±0.06; N=9 
for each genotype; P=0.24). These data show an additive interaction between 
DmGluRA signaling and dFMRP function, which suggests convergent 
mechanisms on GluR regulation.  
 
Discussion 
The finding of elevated Group I mGluR5-dependent hippocampal LTD in the 
fmr1 knockout mouse (Huber et al., 2002) has elicited a great deal of attention 
and excitement. This type of LTD is caused by loss of surface-expression of 
AMPA GluRs, in a mechanism requiring protein synthesis (Huber et al., 2000; 
Huber et al., 2001; Nosyreva and Huber, 2006; Pfeiffer and Huber, 2006). Since 
synaptic protein translation is regulated by FMRP (Weiler et al., 1997; Todd et al., 
2003a; Antar et al., 2004; Weiler et al., 2004; Aschrafi et al., 2005; Qin et al., 
2005b), these observations suggest a mechanistic connection between mGluR 
signaling and FMRP translation regulation in the control of GluR expression at the 
synapse, and indicate that this pathway may be a critical regulator of functional 
synaptic plasticity. This idea has been formally expressed as the ‘mGluR theory of 
FXS’ (Bear et al., 2004). Our study directly investigates this hypothesized 
connection between mGluR signaling, FMRP regulatory function and the synaptic 
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expression of GluRs using the Drosophila FXS model. In Drosophila, there is a 
single FMR1 protein (dFMRP; (Wan et al., 2000; Zhang et al., 2001) and a single 
mGluR (DmGluRA; Parmentier et al., 1996; Bogdanik et al., 2004). dFMRP 
structure, expression and regulative functions closely resemble mammalian 
FMRP (Wan et al., 2000; Zhang et al., 2001; Dockendorff et al., 2002; Morales et 
al., 2002; Lee et al., 2003; Schenck et al., 2003; Ling et al., 2004; Reeve et al., 
2005; Zhang et al., 2005). In contrast, DmGluRA is more homologous to 
mammalian Group II/III mGluRs (Parmentier et al., 1996), not the Group I mGluRs 
implicated in the FMRP mechanism. However, these mGluR class distinctions 
may mean little in Drosophila, with its single mGluR. The mammalian group I 
mGluR antagonist MPEP rescues morphological and behavioral phenotypes in 
dfmr1 null mutants (McBride et al., 2005), and DmGluRA modulates synaptic 
architecture (Bogdanik et al., 2004), which is a known function of mammalian 
Group I mGluRs (Vanderklish and Edelman, 2002). These findings suggest that 
DmGluRA likely occupies the Group I mGluR niche in Drosophila. In any case, 
DmGluRA is the only mGluR capable of mediating glutamatergic signaling in the 
Drosophila system.  
We previously showed that both dfmr1 and dmGluRA mutants have strong 
defects in glutamatergic synaptic function at the Drosophila NMJ (Zhang et al., 
2001; Bogdanik et al., 2004). Neurotransmission at this synapse is mediated by A- 
and B-class AMPA-type GluRs, which have distinctive functional properties, 
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subsynaptic distributions and are regulated by distinct mechanisms (Schuster et 
al., 1991; Petersen et al., 1997; Sigrist et al., 2002; Marrus et al., 2004; 
Featherstone et al., 2005; Qin et al., 2005a). Here, we show in dfmr1 null mutants 
that A-class GluRs accumulate and B-class GluRs are lost (Figure 3.9A). The total 
GluR content does not change, but rather there is a striking shift in the GluR class 
ratio within single postsynaptic domains. This subclass-specific regulation of 
GluRs is a novel finding. In dmGluRA null mutants, we show that both GluR 
classes, and therefore the total GluR population, are significantly increased 
(Figure 3.9A). This is a novel finding for DmGluRA, but consistent with findings in 
mammals showing that GluR1 AMPA receptors are decreased in synaptic 
terminals when mGluR activity is induced (Snyder et al., 2001; Xiao et al., 2001). 
Moreover, we show that postsynaptic over-expression of DmGluRA induces 
exactly opposite changes of A- and B-class GluRs compared to dfmr1 null 
mutants. By testing active zone density and targeted presynaptic rescue of 
dFMRP in the dfmr1 null, we show that the regulatory function of dFMRP on the 
GluR classes is a postsynaptic mechanism. Finally, we show in dfmr1; dmGluRA 
double null mutants that both GluR class phenotypes are additive (Figure 3.9A); 
A-class GluRs increase further with the additive increases of dfmr1 and dmGluRA 
single mutants, and B-class GluRs tend toward normal levels, with the additive 
downregulation in the dfmr1 single mutant and upregulation in the dmGluRA 
single mutant. These results suggested that DmGluRA signaling and dFMRP  
  
 
 
 
 
Figure 3.9: mGluR and dFMRP pathways converge in the regulation of 
iGluRs  
A. Comparison of dfmr1 and dmGluRA single mutants, and dfmr1; dmGluRA 
double mutants in the expression of the three GluR subunits. The WT control is 
set as zero and each bar represents percent change in expression.  
B. Model relating mGluR signaling and FMRP translation regulatory function 
controlling synaptic expression of ionotropic GluR classes. DmGluRA negatively 
regulates both A- and B-class GluRs. dFMRP negatively regulates A-class GluRs 
and positively regulates B-class GluRs. Genetic tests (part A) show that the 
regulation of these two pathways is additive, and therefore that the pathways 
converge on the regulation of these GluR classes. The mGluR theory of FXS 
postulates that these pathways both regulate local postsynaptic mRNA translation; 
activated by mGluR signaling and inhibited by dFMRP. Some newly synthesized 
proteins (Pool 1 mRNA) promote synaptic expression of A-class GluRs, whereas 
others (Pool 2 mRNA) depress synaptic expression of B-classes GluRs. Thus, the 
postsynaptic ratio of A- to B- class GluRs is independently regulated. 
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function converge to regulate the synaptic expression of these two GluR classes, 
but that independent pathways of DmGluRA signaling and dFMRP function also 
exist. 
 
Pre- and postsynaptic functions; overlapping and independent mechanisms 
This study suggests that dFMRP and DmGluRA perform in both overlapping 
and independent pathways in the regulation of postsynaptic GluR classes (Figure 
3.9B). Targeted presynaptic expression of dFMRP in the dfmr1 null fails to provide 
any rescue of class-specific GluR misregulation, showing that the dFMRP 
requirement is in the postsynaptic compartment. Consistently, targeted 
postsynaptic over-expression of DmGluRA causes the opposite class-specific 
GluR misregulation of the dfmr1 null, suggesting an intersection of DmGluRA 
signaling and dFMRP function in the postsynaptic compartment (Figure 3.9B). In 
the dfmr1 null, quantal size is increased (Zhang et al., 2001), a hallmark 
postsynaptic defect. A mechanistic cause suggested by this study is the elevated 
A-class GluR level, consistent with former reports that GluRIIA over-expression 
increases quantal size. Moreover, GluRIIA over-expression increases active zone 
number per bouton, based on the NC82/bruchpilot probe, but does not alter active 
zone density (Sigrist et al., 2002), which is identical to the phenotype reported 
here for dfmr1 mutants. These results support the conclusion that both dFMRP 
and DmGluRA function in the postsynaptic domain in class-specific GluR 
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regulation (Figure 3.9B), and that this mechanism may feedback to alter 
presynaptic properties.  
In addition to the postsynaptic mechanism, there appears to also be 
presynaptic roles of both dFMRP and DmGluRA that can impact the postsynaptic 
GluR domains. We have shown previously that both proteins are expressed in the 
presynaptic neuron of the Drosophila NMJ (Zhang et al., 2001; Bogdanik et al., 
2004). Single null mutants show differential misregulation, with the dfmr1 null 
displaying the class-specific change reflecting its postsynaptic function, but the 
dmGluRA null increasing both GluR classes in common. This must reflect a 
presynaptic function for DmGluRA. Consistently, presynaptic over-expression of 
DmGluRA depresses the level of both A- and B-class GluRs, the opposite 
phenotype as the dmGluRA null. Likewise, presynaptic over-expression of 
dFMRP also reduces B-class GluR expression, although it does not change the 
abundance of A-class receptors. Presumably, these presynaptic roles reflect the 
know functions of dFMRP and DmGluRA in regulating presynaptic glutamate 
release properties, which we have shown previously (Zhang et al., 2001; 
Bogdanik et al., 2004), and therefore the GluR changes reflect transynaptic 
signaling in a homeostatic mechanism. 
By strict genetic criteria, the prediction for the interaction of two proteins 
within a common regulatory pathway is that the mutant phenotype for the gene 
product downstream in the pathway should be epistatic to that of the gene product 
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upstream in the pathway. Clearly, the FMRP translation regulatory activity should 
be downstream of mGluR surface glutamate reception. Such a strict epistatic 
relationship is not observed for DmGluRA and dFMRP in the control of GluR 
expression. Rather, the null mutant phenotypes are obviously additive in double 
mutants (Figure 3.9A). The A-class GluR goes up in both single mutants, and 
goes up further in the double mutant. The B-class GluR goes down in dfmr1 and 
up in dmGluRA, and shows an intermediate, additive level in the double mutant. 
Such additive phenotypes show that dFMRP and DmGluRA have overlapping 
functions but can be operating in the independent pathways (Figure 3.9B). Taken 
together, our results suggest that dFMRP and DmGluRA pathways converge on 
the regulation of GluR synaptic expression, and that this involves both pre- and 
postsynaptic interactions. 
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Experimental Procedures 
 
Drosophila Genetics 
All Drosophila stocks were maintained at 25oC on standard food under 
standard conditions. The w1118; dfmr150M null mutant strain was used as the dfmr1 
single mutant (Zhang et al., 2001), and w1118 was used as its genetic background 
control. The P-element imprecise excision dmGluRA112b null mutant was used as 
the dmGluRA single mutant, and dmGluRA2b (hereafter called 2b), a p-element 
precise excision line from the same screen, was used as its genetic background 
control (Bogdanik et al., 2004). For targeted over-expression studies, lines used 
included w; UAS-dfmr1 (Zhang et al., 2001; Pan et al., 2004), w; UAS-dmGluRA 
(Bogdanik et al., 2004), and the tissue-specific Gal4 drivers ELAV-Gal4 (neural 
specific) and MHC-Gal4 (muscle specific). The following strains were generated 
by standard genetic methods for this study: 1) the dfmr150M; dmGluRA112b double 
null mutant, 2) the dfmr150M; 2b genetic background control combination, 3) the 
ELAV-GAL4; dfmr150M and 4) dfmr150M, UAS-dfmr1. 
 
Immunohistochemistry 
Wandering 3rd instar larvae were dissected in Ca2+-free standard saline 
containing 2mM L-glutamate, followed by ice-cold methanol fixation for 5 minutes. 
The monoclonal mouse antibody against GluRIIA (8B4D2, used at 1:20) was 
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obtained from the Developmental Studies Hybridoma Bank (University of Iowa). 
The polyclonal rabbit antibodies against GluRIIB (used at 1:2000)(Marrus et al., 
2004) and GluRIII/IIC (used at 1:2000)(Marrus et al., 2004) were a generous gift 
from Dr. Aaron DiAntonio (Washington University). The specificity of these GluR 
subunit-specific antibodies has been rigorously demonstrated in western blot 
analyses and genetic tests in subunit-specific null mutants (Yoshihara and 
Littleton, 2002; Marrus et al., 2004; Liebl et al., 2005; Qin et al., 2005a). The 
monoclonal mouse antibody against NC82/bruchpilot (used as 1:200) was 
obtained from the Iowa Developmental Studies Hybridoma Bank (Wagh et al., 
2006). All primary antibodies were visualized using fluorescent dye-conjugated 
secondary antibodies, including Alexa Fluor 488 goat anti-mouse IgG (1:200; 
Molecular Probes), Alexa Fluor 488, 546, and 633 goat anti-rabbit IgG (1:200; 
Molecular Probes), Cy5- and Texas Red- conjugated anti-Horseradish Peroxidase 
(1:200; Jackson). All fluorescent images were collected using a Zeiss LSM 510 
meta laser scanning confocal microscope and image-collection software. All 
image processing was done with Adobe Photoshop 7.0. 
 
Fluorescent intensity quantification 
For any given experiment, animals of control and mutant genotypes were 
simultaneously processed, together in the same tube, and imaged using identical 
confocal settings. A neuronal membrane specific probe, anti-HRP, was used in all 
 112
 113
experiments to label the NMJ synapse and as an internal fluorescence staining 
control. All images used in fluorescent intensity quantification were 3D-projections 
from complete Z-stacks through the entire NMJ on the lateral, longitudinal muscle 
4 in abdominal segment A3. Data from the two-paired hemisegments were 
averaged for each animal, to produce each single data point. All images were 
analyzed using LSM 5 Confocal Image Examiner software in the “histogram” 
display mode. Synaptic regions were user-defined with the closed free shape 
curve drawing tools, defined by the boundary of HRP staining. For quantification, 
multiple synaptic regions were defined, and the fluorescence intensity calculated 
as an average of all regions. The software output reports fluorescence intensity 
for each fluorescent channel and the calculated area for each region. Thus, all 
reports are density measurements. In the direct ratio tests, green channel 
(GluRIIA) intensity was divided by red channel (GluRIIB) intensity to determine 
GluRIIA/GluRIIB ratio in the same synaptic regions. Statistical analysis was done 
using GraphPad InStat 3 software. Significance levels in figures were represented 
as 0.001<P<0.05(*); 0.0001<P<0.001(**); P<0.0001(***). All error bars represent 
SEM (Standard Error of Mean), appropriate for comparison of the mean of means 
distribution. 
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Summary 
Fragile X Syndrome (FXS), the most commonly inherited mental retardation 
disorder, is caused by loss of Fragile X Mental Retardation Protein (FMRP), an 
mRNA-binding regulator of protein translation. A current hypothesis proposes that 
FMRP functions downstream of metabotropic glutamate receptor (mGluR) 
signaling to regulate protein synthesis driving structural/functional changes in 
synapse development and plasticity. Using our Drosophila FXS model, we 
investigate here the mechanistic relationship between dFMRP and the sole 
Drosophila mGluR (DmGluRA) by assaying protein expression, behavioral 
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performance and neuronal structure in brain Mushroom Body (MB) neurons and 
the peripheral NMJ; in dfmr1 and dmGluRA single null mutants, double null 
mutants and with a pharmacological mGluR antagonist. At the protein level, 
dFMRP is upregulated in the dmGluRA null mutant, and DmGluRA is upregulated 
in the dfmr1 null mutant, demonstrating a mutual negative feedback loop. Null 
dmGluRA mutants display behavioral defects in coordinated movement behavior, 
which are rescued by also removing dFMRP expression in the double mutant. 
Null dfmr1 mutants display increased synaptic structural complexity at the NMJ, 
which is partially rescued by  blocking mGluR signaling in dmGluRA double 
mutants or with an mGluR antagonist. Ultrastructurally, dfmr1 null mutants display 
elevated presynaptic vesicle pools, which is also partially rescued in dmGluRA 
double mutant combinations. In the brain MB learning/memory center, dfmr1 null 
neurons display increased presynaptic architectural complexity, which is also 
partially rescued by treating mutants with mGluR antagonist. These data show 
overlapping mechanisms between DmGluRA signaling and dFMRP function in 
the regulation of neuronal architecture and presynaptic properties. 
 
Introduction 
Fragile X syndrome (FXS) is a broad-spectrum neurological disease with 
symptoms including hyperactivity, hypersensitivity to sensory stimuli, mental 
retardation and autism (Turner et al. 1996; Rogers et al. 2001; Visootsak et al. 
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2005). The disease is caused solely by loss of expression of the fragile X mental 
retardation 1 (fmr1) gene, which encodes FMRP, an mRNA-binding protein that 
associates with polyribosomes and acts as a negative translational regulator 
(Garber et al. 2006). A prominent neuronal structure defect found in FXS patients 
and fmr1 knockout mice is denser, longer and immature appearing postsynaptic 
dendritic spines in the cortex, a defect also found in other mental retardation 
diseases (Purpura 1974; Hinton et al. 1991; Irwin et al. 2002; Grossman et al. 
2006). FMRP similarly negatively regulates presynaptic growth and differentiation, 
with increased filipodial extensions from axon growth cones in an fmr1 mouse 
culture system (Antar et al., 2006) and altered presynaptic synaptogenesis in a 
mosaic mouse model of FXS (Hanson and Madison, 2007). FMRP also regulates 
synaptic functional plasticity. A prominent defect in fmr1 knockout mice is 
enhanced long term depression (LTD) in the hippocampus, a  group I class 5 
metabotropic glutamate receptor (mGluR) signaling-induced event (Huber et al. 
2002). This form of LTD requires de novo protein synthesis induced by mGluR 
signaling, which is sensitive to translational inhibitors and dependent on FMRP 
(Huber et al. 2000; Koekkoek et al. 2005; Nosyreva and Huber 2006). Based on 
these findings, a hypothesis has been proposed suggesting that FMRP regulates 
synaptic properties by regulating the level of protein synthesis downstream of 
mGluR signaling; “the mGluR theory of FXS” (Bear et al. 2004; Pfeiffer and Huber 
2006). 
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Drosophila provides a powerful genetic model system to test this hypothesis. 
The Drosophila genome contains only one fmr1 homolog (dfmr1) and encodes a 
single functional mGluR (DmGluRA) (Parmentier et al. 1996; Wan et al. 2000; 
Zhang et al. 2001; Bogdanik et al. 2004). Null mutants of both genes are viable 
and therefore accessible to neurological studies throughout life. As in the 
mammalian system, null dfmr1 mutants display structural overgrowth and 
overbranching of both presynaptic and postsynaptic processes, which has been 
well-characterized in both the larval glutamatergic neuromuscular junction (NMJ) 
and the adult central brain Mushroom Body (MB) learning/memory center (Zhang 
et al. 2001; Lee et al. 2003; Michel et al., 2004; Pan et al. 2004; McBride et al., 
2005). Loss of dFMRP also causes altered synaptic differentiation and/or function 
in the visual system, brain MB and NMJ (Zhang et al. 2001; Pan et al. 2004; 
Zhang and Broadie 2005). DmGluRA is synaptically localized in both CNS 
synaptic neuropil and at the NMJ (Parmentier et al. 1996; Bogdanik et al. 2004). 
DmGluRA is a sequence ortholog of mammalian group II/III mGluRs but, as the 
sole Drosophila mGluR, presumably takes on all GluR signaling functions 
subdivided between group I-III mGluRs in mammals. Null dmGluRA mutants 
display altered synaptic architecture at the NMJ and also strong defects in 
activity-dependent functional plasticity at the NMJ (Bogdanik et al. 2004). Roles 
of DmGluRA in the CNS have not yet been investigated. These data show that 
dFMRP and DmGluRA modulate synaptic architecture and function in the same 
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or closely related processes. 
Treatment with a group I mGluR antagonist (MPEP) can rescue two major 
FXS behavioral phenotypes in fmr1 knockout mice, habituation in open field tests 
and increased sensitivity to audiogenic seizures (Yan et al. 2005). Similarly, 
treating dfmr1 null mutant flies with either MPEP (Group I mGluR antagonist), or 
LY341495, MPPG, or MTPG (Group II/III mGluR antagonists), can effectively 
rescue behavioral and gross brain morphological defects, including male 
courtship learning/memory defects and β-lobe fusion in the Mushroom Body 
(McBride et al. 2005). These results have strongly supported a mechanistic 
relationship between DmGluRA signaling and dFMRP function. The fact that 
antagonists of different mammalian mGluR classes can equally rescue dfmr1 null 
phenotypes (McBride et al. 2005), suggests that DmGluRA does indeed mediate 
group 1 mGluR signaling or, alternatively, that the connection between FMRP 
function and mGluR signaling might be broader than is currently appreciated. The 
identification and elucidation of the molecular and cellular relationships between 
mGluR signaling and FMRP will significantly increase understanding on the 
mechanism of FXS, and provide insights into potential therapeutic treatments for 
the disease.  
In this study, we examine mechanistic relationships between DmGluRA 
signaling and dFMRP function at the genetic, molecular and cellular levels. We 
find that dFMRP protein is increased in dmGluRA null mutant CNS, and that 
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DmGluRA protein is similarly increased in dfmr1 null mutants, showing a 
molecular feedback regulation mechanism. DmGluRA and dFMRP interact in the 
regulation of coordinated movement behavior, and in the regulation of synaptic 
architecture at the NMJ. Ultrastructure analyses show greatly increased synaptic 
vesicle pools in dfmr1 null synaptic boutons, which are largely restored to normal 
by also removing DmGluRA function. In the brain, blocking DmGluRA signaling 
rescues single-cell architectural defects in dfmr1 null neurons. Taken together, 
these data suggest that convergent cross-talk between DmGluRA signaling and 
dFMRP function controls neuron structure and presynaptic differentiation. 
 
Results 
 
DmGluRA and dFMRP mutual negative feedback loop 
Previous work has shown that dFMRP and DmGluRA are both localized in 
the nervous system (Parmentier et al. 1996; Ramaekers et al. 2001; Zhang et al. 
2001; Dockendorff et al. 2002), but the spatial relationship between them has not 
been clear. Just like mammalian FMRP, dFMRP appears to be pan-neuronally 
expressed with similar levels in most/all neurons, and is primarily localized in the 
neuronal soma cytoplasm with little/no detectable expression in the nucleus and 
only very faint expression in distal neuronal processes (Verheij et al., 1993; Feng 
et al., 1997; Zhang et al., 2001; Antar et al., 2004; Pan et al., 2004; Bagni and 
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Greenough 2005). In the Drosophila larval CNS, dFMRP is concentrated in all 
neuronal soma, including midline motor neuron soma, but largely undetectable in 
the synaptic neuropil (Figure 4.1A). In direct contrast, DmGluRA is specifically 
concentrated at synaptic connections (Bogdanik et al., 2004). In the Drosophila 
larval CNS, DmGluRA is undetectable in neuronal soma but appears throughout 
the synaptic neuropil (Figure 4.1A). DmGluRA therefore also appears 
pan-neuronal, although this is impossible to say for sure in the absence of 
neuronal soma localization. Thus, dFMRP is primarily localized in neuronal cell 
bodies, whereas DmGluRA is primarily localized in synaptic neuropil (Figure 
4.1A). The two proteins have a largely non-overlapping expression pattern in the 
same neurons. 
The mGluR theory of FXS proposes that FMRP expression is negatively 
regulated by mGluR signaling (Bear et al. 2004; Pfeiffer and Huber 2006). We 
therefore first asked whether DmGluRA signaling may regulate dFMRP by 
examining dFMRP protein expression in the dmGluRA112b null mutant with a 
companion precise excision line, 2b, as the genetic background control (Figure 
4.1A; top, green). The antibody against dFMRP does not produce any signal in 
dfmr1 null mutants (data not shown), proving antibody specificity. The level of 
dFMRP is clearly and consistently upregulated in dmGluRA null mutants (Figure 
4.1A). There is no detectable change of the expression pattern, but rather just a 
greatly heightened dFMRP expression in neuronal soma. Given this evident 
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regulation, we next asked whether dFMRP may also regulate DmGluRA protein 
levels. The dfmr150M null mutant was assayed, with w1118 as the genetic 
background control (Figure 4.1A; bottom, red). The antibody against DmGluRA 
does not produce any signal in dmGluRA112b (data not shown), proving antibody 
specificity. The synaptic neuropil expression of DmGluRA is increased in the 
dfmr1 null mutants (Figure 4.1A). As in the case of dFMRP, there is no detectable 
change in the pattern of expression, just an increase in the DmGluRA protein 
level in the synaptic neuropil. 
To further examine the interaction between dFMRP and DmGluRA, we 
performed immunocytochemistry at an electron microscope level on ultrathin 
sections through the third instar CNS (Figure 4.1B). Both primary antibodies were 
visualized by secondary antibodies directly conjugated to gold beads (10nm 
diameter). In null mutant controls, the background level of adherent gold beads 
was virtually undetectable (data not shown), once again demonstrating antibody 
specificity. The dFMRP label was localized to cellular cytoplasm in neurons, often 
with several gold particles localized on or near large (~100nm), uniform 
dense-core granules resembling stress granules or P-bodies (Figure 4.1B, top). 
In the dmGluRA112b null mutant, the density of dFMRP gold particle label was 
clearly increased compared to controls (Figure 4.1B; top, arrows). The CNS 
neuropil is densely packed with many synaptic structures, including prominent 
synaptic terminals filled with mitochondria and synaptic vesicles. The synaptic  
  
 
 
 
Figure 4.1. DmGluRA and dFMRP display mutual negative regulation. 
A. Representative images of dFMRP (green) and DmGluRA (red) expression 
patterns in third instar larval CNS in wildtype (WT), dfmr1 null mutant, and 
dmGluRA null mutant. Both dFMRP and DmGluRA are highly enriched in CNS 
neurons, with dFMRP primary localized in neuronal cell bodies (cb), and 
DmGluRA primary localized in synaptic neuropil (np). Expression was assayed for 
each protein in the respective opposing null mutant. dFMRP level is clearly 
increased in dmGluRA null mutants, and DmGluRA level is also increased in 
dfmr1 null mutants. The scale bar is 10μm.  
B. Immuno-EM localization of dFMRP and DmGluRA in third instar larval CNS.  
Wildtype (WT), dfmr1 and dmGluRA null mutants immuno-labeled with 10nm gold 
particles against dFMRP (top) and DmGluRA (bottom). Arrows indicate 
representative clusters of immunogold particles in each case. Insets show higher 
magnification images of the gold label in each case. In dmGluRA mutants, there is 
a clear increase of gold particle number of dFMRP labeling. Similarly, a clear 
increase of DmGluRA labeling is also observed in dfmr1 null mutants. The scale is 
250nm. 
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arborizations are very small (<500nm mean diameter) with a packing density that 
exceeds by several fold the highest density found among vertebrate neurons 
(Strausfeld 1998). Immunogold labeling of DmGluRA shows a moderate level of 
protein associated with synaptic membranes (Figure 4.1B, bottom). In the 
dfmr150M null mutant, the density of DmGluRA gold particle label was clearly 
increased compared to the genetic control (Figure 4.1B; bottom, arrows). Taken 
together, both fluorescent confocal microscopy and immunogold electron 
microscopy reveal that dFMRP and DmGluRA negatively regulate each other’s 
expression in the same neurons. This reciprocal regulation between dFMRP and 
DmGluRA shows a negative feedback mechanism exists between DmGluRA 
signaling and dFMRP expression. 
 
DmGluRA and dFMRP genetically interact in behavioral movement 
regulation 
Behavioral tests of coordinated movement involve the integration of several 
sensory input modalities, coupled to sequential motor output driving the 
appropriate movement response. We previously devised a simple but effective 
test called the “roll-over” assay to measure such coordinated behavior in the 
Drosophila larva (Bodily et al. 2001). This assay involves placing wandering third 
instar larva on a smooth agar plate, turning the animal to a totally inverted 
position and then measuring the time the animal takes to fully right itself to the 
normal position. This behavior requires the integration of sensory stimuli and 
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coordinated bilateral motor control to produce the necessary sequence of 
movements. We used this assay to test dfmr1 and dmGluRA single null mutants 
for possible defects in coordinated movement behavior, and then double null 
mutant combinations for modulation of behavioral responses. 
Loss of DmGluRA signaling strongly impairs coordinated movement 
behavior, with the average response time lengthened by 50% (Figure 4.2). In 
individual animals, the behavioral defect was clearly evident as a combination of 
inappropriate movement responses and defects in cooperative motor control. The 
dmGluRA mutant animals appear to “struggle” during a period of continuous, 
spastic muscle contractions that do not aid in the tuning over behavior, while 
wildtype animals always display smooth, cooperative motor control to turn over 
quickly. Quantitatively, dmGluRA null mutants display a very significantly slowed 
performance compared to the genetic wildtype (WT) control in this coordinated 
behavior (WT=12.4±0.7 sec, N=46; dmGluRA=18.4±1.15 sec, N=49; P<0.0001; 
Figure 4.2). In contrast, removal of dFMRP alone causes no defect in this 
coordinated behavior. We used two independent dfmr1 null mutant lines, dfmr150M 
and dfmr13 (Zhang et al. 2001; Dockendorff et al. 2002), and crossed them into 
the same genetic control (2b) background shared with dmGluRA. Both dfmr150M 
and dfmr13 null mutants perform comparably to the control in this coordinated 
movement assay (WT=12.4±0.7 sec, N=46; dfmr150M=12.9±1.04 sec, N=43, 
P=0.71; dfmr13=12.3±0.65, N=33; P=0.92; Figure 4.2). Therefore, loss of dFMRP 
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alone does not detectably impair the coordinated movement in the roll-over 
assay. 
To examine the relationship between DmGluRA signaling and dFMRP 
function in coordinated movement behavior, we tested the performance of two 
double mutant combinations; dfmr150M; dmGluRA and dfmr13; dmGluRA (Figure 
4.2). Both double null mutant lines displayed a remarkable rescue of the 
behavioral impairment caused by loss of mGluR signaling. In individual double 
mutant animals, the roll-over behavioral response was smooth and efficient, with 
a significantly shorter “struggle” time compared to the dmGluRA null. 
Quantitatively, the double null mutant showed comparable behavior to the 
wildtype control, with a very significant rescue of the impaired performance 
compared to the dmGluRA single mutant (dfmr150M;dmGluRA=9.0±0.62 sec, 
N=45, P<0.0001 to dmGluRA; dfmr13;dmGluRA=14.2±0.69 sec, N=34, P=0.007 
to dmGluRA; Figure 4.2). It is not clear why the dfmr150M combination actually 
shows improved response time compared to the control, but the average 
response time for the two double null mutants (11.6 seconds) is quite comparable 
to the wildtype performance (12.4 seconds), with no significant difference. 
Therefore, the coordinated movement behavior defect in the dmGluRA null 
mutant can be effectively rescued by removing dFMRP function. 
 
 
  
 
 
 
 
 
 
Figure 4.2. DmGluRA and dFMRP genetically interact in coordinated 
movement. 
Coordinated movement behavior requires integration of sensory input and motor 
output. One test for this integration is the larval roll-over assay in which larvae are 
inverted and their righting time measured. Null dmGluRA mutants show a highly 
significant increase in response time, indicating grossly slowed performance. Two 
independent dfmr1 null alleles behave normally. However, both double mutant 
combinations significantly rescue the slow performance of the dmGluRA null. 
0.001<P<0.05(*); P<0.0001(***). 
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DmGluRA and dFMRP genetically interact in regulating NMJ structure 
Treating dfmr1 null flies with the mammalian group I mGluR antagonist 
MPEP rescues gross brain anatomical defects (McBride et al. 2005), suggesting 
that dFMRP and DmGluRA may be involved in the same mechanisms regulating 
neuronal structure. The Drosophila glutamatergic NMJ is an ideal system to test 
this hypothesis, since previous work has shown that both dfmr1 and dmGluRA 
single mutants display significant NMJ structure defects (Zhang et al., 2001; 
Bogdanik et al., 2004). The availability of the dfmr1; dmGluRA double mutant 
combinations produced here provides the opportunity for the most rigorous 
genetic test of the relationship between dFMRP and DmGluRA in this synaptic 
architectural patterning. NMJ structure was examined in dfmr1 and dmGluRA 
single null mutants, dfmr1; dmGluRA double mutants, and MPEP treated dfmr1 
null mutants and controls. The muscle 4 NMJ in abdominal segment A3 was used 
in all studies, with NMJs co-labeled for the presynaptic marker HRP (Figure 4.3, 
red) and the postsynaptic marker DLG (Figure 4.3, green). NMJ synaptic 
structure was quantified by measuring synaptic branch number, synaptic terminal 
area and synaptic bouton number (Figure 4.4).  
For synaptic branch number, dfmr1 single mutants display a very highly 
significant overbranching phenotype, while dmGluRA single mutants display 
branching comparable with the genetic control (WT=2.89±0.11, N=15; 
dfmr1=6.32±0.33, N=15, P<0.0001; dmGluRA=3.4±0.35, N=11, P=0.15; Figure 
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4.3A-C, 4.4A). The dfmr1; dmGluRA double mutants display a tendency towards 
the normal level of synaptic branching with a significant rescue of the dfmr1 
mutant defect (dfmr1; dmGluRA=5.5±0.38, N=11; P=0.039 to dfmr1; Figure 4.3F, 
4.4A). Consistently, treating dfmr1 null mutants with the mGluR antagonist MPEP, 
which blocks mGluR signaling, also effectively rescues the dfmr1 overbranching 
phenotype with no difference remaining with the control (MPEP-treated 
WT=3.5±0.3, N=11; MPEP-treated dfmr1=3.63±0.29, N=11, P=0.62 to treated WT; 
Figure 4.3D-E, 4.4A). Thus, blocking DmGluRA signaling significantly rescues the 
synaptic overbranching phenotype of dfmr1 mutants. 
For synaptic terminal area, dfmr1 single mutants display a very significant 
increase in total area, while dmGluRA mutants display a slight, marginally 
significant decrease in synaptic area compared to the genetic control 
(WT=458.52±12.96μm2, N=15; dfmr1=597.45±29.61μm2, N=15, P=0.0007; 
dmGluRA=426.61±10.89μm2, N=11, P=0.078; Figure 4.3A-C, 4.4B). The dfmr1; 
dmGluRA double mutants do not show any rescue of the increased synaptic area 
characteristic of dfmr1 alone, which therefore remains highly elevated compared 
to control (dfmr1; dmGluRA=622.88±15.77μm2, N=11; P=0.46 to dfmr1; Figure 
4.3F, 4.4B). The dfmr1 null mutants treated with the mGluR antagonist MPEP do 
display significantly decreased synaptic area compared to non-treated mutants 
(MPEP-treated dfmr1=499.95±24.88μm2, N=11, P=0.0048 to non-treated dfmr1). 
However, MPEP-treated control animals display a similar decrease compared to 
  
 
 
 
 
Figure 4.3. DmGluRA and dFMRP genetically interact in regulating NMJ 
structure. 
Wandering 3rd instar NMJs were probed using anti-HRP (red) and anti-DLG 
(green) antibodies, to reveal pre- and postsynaptic domains respectively. 
Representative images of the NMJ on muscle 4 in abdominal segment A3 are 
shown.  
A. The wildtype (WT) 2b genetic background control.  
B. Null dfmr1 mutant allele dfmr150M in the 2b genetic background.  
C. Null dmGluRA mutant allele dmGluRA112b in the 2b genetic background.  
D. WT animal fed 68 μM MPEP. E. Null dfmr1 mutant fed 68 μM MPEP. F. Double 
mutant dfmr150M; dmGluRA112b in the 2b genetic background. Null dfmr1 mutants 
display increased NMJ synaptic branch number, terminal area and synaptic 
bouton number. MPEP-treatment and dfmr1; dmGluRA double mutant rescue the 
increased branch number, but not the other two defects. The scale bar is 10μm. 
 
 
 
 
 
 
 131
  
 
 
 
 
 
 
 
 
 
 
 132
 133
on-treated control, and therefore the difference between the MPEP-treated 
hly 
signi
n
wildtype control and the MPEP-treated dfmr1 null mutant is still extremely 
significant (MPEP-treated WT=330.53±21.81μm2, N=11, P<0.0001; Figure 
4.3D-E, 4.4B). Therefore, blocking DmGluRA signaling does not significantly 
rescue the increased synaptic terminal area characteristic of dfmr1 mutants.  
For synaptic bouton number, dfmr1 single mutants display a very hig
ficant increase, whereas dmGluRA mutants display a small, opposing 
decrease in bouton number compared to control animals (WT=29.7±1.48, N=15; 
dfmr1=36.5±1.5, N=15, P=0.001; dmGluRA=24.94±1.17, N=11, P=0.02 to WT; 
Figure 4.3A-C, 4.4C). Surprisingly, the dfmr1; dmGluRA double mutants do not 
show the additive effects of the opposite phenotypes of the two single mutants, 
but rather display an even more severe, synergistic increase in synaptic bouton 
number compared to the dfmr1 single mutants (dfmr1; dmGluRA=42.3±2.09, 
N=11; P=0.037 to dfmr1; Figure 4.3F, 4.4C). Consistently, treating dfmr1 null 
mutants with the mGluR antagonist MPEP also does not rescue the increased 
bouton defect of the dfmr1 mutant. Indeed, the difference between MPEP-treated 
control and MPEP-treated dfmr1 is more significant than the comparison of 
non-treated control and non-treated dfmr1 (MPEP-treated WT=28.27±2.14, N=11; 
MPEP-treated dfmr1=39.27±1.51, N=11, P=0.0004, Figure 4.3D-E, 4.4C). Thus, 
either genetic or pharmacological block of DmGluRA signaling further 
exaggerates the synaptic bouton over-proliferation caused by loss of dFMRP. 
  
 
 
 
 
 
Figure 4.4. Quantification of NMJ structure in single and double mutants. 
A. Quantification of NMJ synaptic arbor branch number for all genotypes. Null 
dfmr1 mutants display a highly significant increase of branch number, which can 
be rescued by blocking DmGluRA signaling genetically (double mutant) and 
pharmacologically (MPEP).  
B. Quantification of terminal synaptic area for all genotypes. Null dfmr1 mutants 
display a very significant increase of synaptic area, which is unaltered by blocking 
DmGluRA signaling in double mutant combination or with MPEP antagonist.  
C. Quantification of total synaptic bouton number for all genotypes. Null dfmr1 
mutants display a very significant increase of bouton, whereas dmGluRA mutants 
display a significant decrease. Double mutants and MPEP-treated dfmr1 mutants 
display synergistically increased bouton number. 0.001<P<0.05(*); 
0.0001<P<0.001(**); P<0.0001(***). 
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Taken together, these results show a complex interaction between dFMRP 
and DmGluRA in regulating different aspects of presynaptic architecture. 
Whereas the synaptic over-branching caused by loss of dFMRP can be rescued 
by co-removal of DmGluRA or pharmacological block of mGluR signaling, the 
supernumerary boutons formed in the absence of dFMRP proliferate even more 
wildly when DmGluRA signaling is blocked. Thus, dFMRP and DmGluRA 
functions overlap in common mechanisms, but not in a simply interpretable 
manner. 
 
DmGluRA and dFMRP genetically interact in regulating synaptic 
ultrastructure 
Electron microscopy is the best means available to assay the complex 
assemblage occurring as a product of synaptic differentiation (Figure 4.5). The 
presynaptic NMJ bouton is characterized by multiple, large mitochondria, dense 
accumulations of ~40nm synaptic vesicles, an electron-dense active zone, and 
clustered vesicles around and docked adjacent to the T-bar presynaptic fusion 
sites. This bouton is deeply embedded in muscle and surrounded by the 
maze-like subsynaptic reticulum (SSR), which demarcates the postsynaptic 
domain (Figure 4.5A). A detailed ultrastructural examination includes multiple 
parameters such as presynaptic bouton area and appearance, postsynaptic SSR 
area and appearance, mitochondria area and appearance, size and structure of 
the active zone and quantification of the different presynapti  c vesicle pools
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(Figu
dfmr1 mutants display significant increases of synaptic vesicle density 
roughout the synaptic bouton, clustered vesicle number surrounding active 
syna
re 4.5). At the ultrastructural level, the overall appearance of bouton and the 
postsynaptic SSR morphology appears normal in both dfmr1 and dmGluRA 
single null mutants. Quantitatively, there is no significant difference in bouton size, 
mitochondria size, active zone size/number or the postsynaptic SSR parameters 
between control and mutants (Figure 4.5A and data not shown). However, there is 
a clear change in presynaptic vesicle density in the dfmr1 mutant, which we 
therefore carefully assayed in single and double mutant combinations. 
Null 
th
zones and docked vesicle number at the T-bar membrane (Figure 4.5A, B). For 
ptic vesicle density, single dfmr1 null mutant display a highly significant 
~30% increase in overall vesicles, whereas dmGluRA mutants show vesicle 
density comparable to the genetic control (WT=56.36±5.6 vesicles/μm2, N=61; 
dfmr1=87.89±5.6 vesicles/μm2, N=40, P=0.0002; dmGluRA=59.94±4.4 
vesicles/μm2, N=51, P=0.62; Figure 4.5A, C). The dfmr1; dmGluRA double 
mutants show a very significant rescue of this elevated vesicle density phenotype 
(dfmr1; dmGluRA=64.22±2.8 vesicles/μm2, N=75, P=0.001 to dfmr1, P=0.14 to 
WT, Figure 4.5A, C). Therefore, removing DmGluRA signaling can rescue the 
abnormal presynaptic vesicle accumulation characteristic of dfmr1 null synapses.  
The synaptic vesicles clustered around the active zone form a local pool that 
can quickly replenish vesicles used during transmission (Figure 4.5B). These 
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thus very 
signi
(WT=
vesicles are quantified by drawing a circle of 250nm around the electron dense 
T-bar and counting the number of synaptic vesicles within this radius. Null dfmr1 
mutants display a highly significant ~50% increase in the pool of clustered 
vesicles, whereas dmGluRA mutants make vesicle pools comparable to control 
(WT=13.1±0.8; dfmr1=18.8±0.7, P=0.0001; dmGluRA=14.6±0.8, P=0.22; Figure 
4.5B, D). The dfmr1; dmGluRA double mutants display a significant reduction in 
the clustered vesicle pool compared to the dfmr1 single mutant, and 
ficantly rescue the dfmr1 mutant phenotype (dfmr1; dmGluRA=16.3±0.4, 
P=0.005 to dfmr1; Figure 4.5B,D). Therefore, removing DmGluRA signaling can 
also effectively rescue the increased clustered synaptic vesicle pool of the dfmr1 
null mutant.  
To provide for the rapidity of synaptic transmission, a subset of synaptic 
vesicles are maintained docked at active zones, where they form a pool that is 
immediately releasable upon arrival of an action potential. Electron microscopy 
reveals a population of synaptic vesicles morphologically adjacent to the 
presynaptic electron-dense membrane, which are considered to be these docked 
vesicles (Figure 4.5B, arrows; Couteaux and Pecot-Dechavassine, 1970). Null 
dfmr1 mutants display a highly significant ~85% increase in the number of docked 
vesicles at the active zone, whereas dmGluRA mutants appear totally normal 
1.5±0.12; dfmr1=2.8±0.18, P=0.0001; dmGluRA= 1.5±0.14, P=0.92, Figure 
4.5B, E). In contrast to the above two vesicle pools, removing DmGluRA signaling 
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 4.5. DmGluRA and dFMRP genetically interact in presynaptic 
ructure. 
resentative TEM images of NMJ boutons in 2B genetic background control 
t. The dfmr1 mutant has a slightly larger bouton size but comparable 
panels as electron-dense synaptic membranes and T-bars. Null dfmr1 
ale bar is 500nm.  
s (far left) the clustered area (250nm radius from T-bar center) has ~13 
rows). The dmGluRA null mutants (second from right) display no 
 and clustered synaptic vesicle number are comparable to control, but the 
ative analysis of ultrastructural phenotypes, including synaptic vesicle 
 (C), clustered synaptic vesicles (D; <250nm from active zone) and docked 
ve zone). Significance indicated as 
P<0.05(*); 0.0001<P<0.001(**); P<0.0001(***). 
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does not detectably rescue the increased docked vesicle number characteristic of 
e dfmr1 null mutants. The dfmr1; dmGluRA double mutants, the elevation in 
ocked vesicle number is indistinguishable from the dfmr1 single mutant alone 
(dfmr1; dmGluRA=2.5±0.09; P=0.19 to dfmr1, P=0.0001 to WT, Figure 4.5B, E). 
Thus, removing DmGluRA signaling does not rescue the increased docked 
vesicle pool characteristic of dfmr1 mutants. 
Taken together, these data also suggest that there is a complex interaction 
between dFMRP and DmGluRA signaling in regulating presynaptic differentiation. 
Loss of dFMRP results in large increases of presynaptic vesicle pools. Removing 
DmGluRA function alone has no effect on these vesicle pools, however removing 
DmGluRA in the double mutant condition can effectively rescue the enhanced 
overall vesicle density and increased clustered vesicle pools of the dfmr1 null 
mutant. In contrast, the number of docked vesicles remains elevated. These 
results suggest partially overlapping mechanisms between dFMRP and 
DmGluRA in the regulation of presynaptic differentiation at the peripheral NMJ.    
 
DmGluRA and dFMRP interact in regulating central neuron structure 
The Mushroom Body (MB) is a learning and memory center in the 
Drosophila brain (Heisenberg 1998; Heisenberg 2003). Our previous work has 
shown that dfmr1 null mutant MB neurons display increased overall architectural 
complexity, including axonal overgrowth and overbranching (Pan et al. 2004). The 
th
d
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 architectural defects in single cell 
MAR
lones identified by GFP (green) expression (Figure 4.6A). The MB γ neuron 
ft, box) 
(Lee
Mosaic Analysis of Repressible Cell Marker (MARCM) clonal technique provides 
a uniquely powerful means to examine homozygous mutant neurons in situ at a 
single cell level of resolution and therefore to study the cell autonomous functions 
for the mutant gene (Lee and Luo 1999). To test the mechanistic relationship 
between dFMRP and DmGluRA in central nervous system, we asked whether 
blocking DmGluRA signaling can rescue the
CM clones of dfmr1 null MB neurons. The dfmr1 gene is located on the third 
chromosome, while the dmGluRA gene is on fourth chromosome. It is technically 
not possible to do MARCM analysis for double mutants. However, our NMJ work 
shows that MPEP mGluR antagonist treatment totally mimics the effects of 
removing DmGluRA expression in all cases studied. Therefore, we used MPEP to 
treat MARCM clonal animals to assay the effect of blocking DmGluRA signaling 
on dfmr1 null MB neurons. 
In MARCM clone brains, the MB axon lobes were visualized with an 
antibody against Fasciclin II (FasII, red), and the single-cell γ neuron MARCM 
c
contains a single primary axon projection in control animals (Figure 4.6A; le
 et al. 1999). The branching features of the γ neuron axon projection can be 
quantified both by branch number and total branch length. Null dfmr1 mutant MB 
neurons display obvious axon overgrowth; both the axon branch number 
(WT=6.2±0.5, N=10; dfmr1=10±0.7, N=12; P=0.0008) and the total axon branch 
  
 
 
 
 
Figure
brain.  
A. Rep
neuron. The Mushroom Body axon lobes are labeled with an antibody against 
Fascic
technique-induced GFP expression (green). The boxed area indicates the axonal 
project
B. Representative images of axons in a non-treated WT cell, a non-treated dfmr1 
null mu
non-treated dfmr1 null γ neuron axon displays significant over-growth and 
over-b
C-D. Q  number (C) and total axon branch length (D) in 
both genot  treatment. Compared to the significant 
increase of 
dfmr1 null, MPEP-treated 
over-g
 
 
 
 
 
 
 4.6. Blocking mGluR signaling rescues dfmr1 null neuron defects in 
resentative image of single cell MARCM clone of a Mushroom Body γ 
lin II (FasII, red). The single γ neuron is visualized by MARCM 
ion shown in the B panels.  
tant cell, a MPEP-treated WT cell and a MPEP-treated dfmr1 null cell. The 
ranching, which is effectively rescued by MPEP treatment.  
uantification of axon branch
ypes, with or without MPEP
both axonal branch number and cumulative axon length in non-treated 
dfmr1 mutant neurons display significant rescue of 
rowth phenotypes. 0.001<P<0.05(*); 0.0001<P<0.001(**). 
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length (WT=62.2±2.3 μm; dfmr1=82±3.2 μm; P=0.0006) are very significantly 
creased in dfmr1 null neurons (Figure 4.6B-D). Treating MARCM clone animals 
with the mGluR antagonist MPEP can effectively rescue the axon overgrowth 
defects of dfmr1 null mutant neurons. Blocking mGluR signaling with MPEP 
produces a significant rescue of the increased axon branching defect in dfmr1 null 
neurons (MPEP-dfmr1=8.4±0.9, N=8, P=0.05 to non-treated dfmr1=10±0.7). 
Similarly, the axon overgrowth defect is countered by MPEP treatment 
(MPEP-dfmr1=73.4±2.9 μm, P=0.06 to non-treated dfmr1=82±3.2 μm). Thus, 
MPEP-treated dfmr1 mutant neurons resemble control neurons compared to 
non-treated dfmr1 mutants, although the rescue provided by MPEP treatment is 
partial. Therefore, blocking mGluR signaling by MPEP can rescue the central 
neuron presynaptic over-elaboration defect of dfmr1 null mutants. 
 
Discussion 
Drosophila is a powerful system to test the mGluR theory of Fragile X 
Syndrome. There is one Drosophila homolog of the 3-member mammalian FMRP 
gene family (dFMRP) (Wan et al. 2000; Zhang et al. 2001) and one Drosophila 
homolog of the 8-member mammalian mGluR family (DmGluRA) (Parmentier et 
al. 1996; Bogdanik et al. 2004). Therefore, the double mutant combination of the
o Drosophila null alleles provides a unique opportunity to test the relationship 
etween all FMRP family function and all mGluR signaling throughout the 
in
 
tw
b
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nervous system. Of course this is a two-edged argument; Drosophila does not 
provide the means to test family member specific functions within or between 
these gene families, and so this sophistication of the mammalian system cannot 
be addressed. Nevertheless, Drosophila provides an excellent opportunity to 
comprehensively test interactions between mGluR signaling and FMRP functions 
in the in vivo context of the whole nervous system. 
  The mGluR theory of FXS proposes that FMRP functions downstream of 
mGluR signaling to regulate the synthesis of proteins critical for synaptic 
structural modeling and functional synaptic plasticity (Bear et al., 2004; Bagni and 
Greenough, 2005; Grossman et al., 2006; Pfeiffer and Huber, 2006). FMRP is a 
negative regulator of translation, and most known FMRP targets are constitutively 
upregulated in the absence of FMRP (Brown et al., 2001; Laggerbauer et al., 
001; Sung et al., 2003; Bagni and Greenough, 2005). One FMRP target is its 
own message, providing an interesting negative feedback loop on FMRP 
expre
2
ssion (Ashley et al., 1993; Sung et al., 2000; Schaeffer et al., 2001). In this 
work, we find that dFMRP and DmGluRA also mutually negatively regulate each 
other’s expression levels (Figure 4.1). The protein level of dFMRP is increased in 
the dmGluRA null mutant, and the DmGluRA level is increased in the dfmr1 null 
mutant, providing bidirectional negative feedback regulation between the two 
proteins. Although these two proteins are co-expressed in the same neurons, 
consistent with their mutual co-regulation, they occupy quite distinct subcellular 
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domains (Figure 4.1); dFMRP is highly enriched in the soma cytoplasm and is 
largely undetectable at synapses, whereas DmGluRA is highly enriched in the 
synaptic plasma membrane and is largely undetectable in the soma. This protein 
distribution suggests that the effect of mGluR signaling on dFMRP expression 
must be somewhat indirect, involving a long-distance second messenger 
mechanism. The increase in dFMRP level in the absence of mGluR signaling is 
somewhat surprising in light of mammalian studies showing that increased 
synaptic activity increases FMRP expression and, more specifically, that mGluR 
activation increases FMRP expression (Weiler et al., 1997; Todd et al., 2003). The 
current study suggests instead that the overall role of mGluR signaling is to 
strongly suppress FMRP expression in the nervous system, at least in Drosophila. 
The increase in the DmGluRA in the absence of dFMRP indicates that the 
receptor is negatively regulated by dFMRP function.  Some studies have 
suggested that mGluR transcripts may be direct targets for FMRP binding and, 
presumably, negative translation regulation. Such a mechanism would be 
consistent with the findings of this study. However, such direct regulation is not 
required, as there is obviously numerous possibilities of indirect regulation. In any 
case, the existence of this mutual negative feedback loop shows that mGluR 
signaling and FMRP function clearly interact to mutually repress each other in the 
Drosophila nervous system, providing molecular support for the theory of their 
functional interaction.  
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Both Group I and Group II/III mGluRs have been shown to play roles in the 
generation of locomotor activity and regulation of movement behavior (Vezina 
and Kim, 1999; Cauli et al., 2005; Nistri et al., 2006). In Drosophila, mGluR 
signaling is similarly required for effective performance in coordinated movement 
behavior (Figure 4.2). Null dmGluRA mutants display a grossly slowed response 
time in a relatively simple movement behavior, as revealed by the roll-over assay, 
indicating sluggish integration of sensory input and sequential motor output. 
Obviously, there are many possible causes of such a behavioral defect. In 
contrast, dfmr1 null mutants perform this task as well as wildtype. This is 
somewhat surprising given that dfmr1 mutants are more obvious impaired than 
dmGluRA mutants in many published cellular assays of synaptic structuring and 
function (Zhang et al., 2001; Bogdanik et al., 2004; Xu et al., 2004). The most 
important finding here, however, is that the dmGluRA defect can be rescued 
entirely simply by removing dFMRP in double null mutants (Figure 4.2). This is a 
rather remarkable finding as it shows that the behavioral impairment caused by 
the absence of mGluR signaling can be entirely compensated for by the 
co-absence of FMRP function. Although the nature of the dysfunction is unknown, 
this interaction shows that FMRP must act to enable a mechanism that is over 
active in the absence of mGluR signaling; a mechanism important for facilitating 
coordinated movement behavior. These results provide in vivo genetic evidence 
for a functional connection between dFMRP and DmGluRA in the sensory and 
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motor response loop.  
One obvious place for dFMRP-DmGluRA pathway regulation is the NMJ 
synapse. Both dfmr1 and dmGluRA single null mutants display striking defects in 
NMJ synaptic properties (Zhang et al. 2001; Bogdanik et al. 2004). Null dfmr1 
mutants display elevated synaptic branch number, increased synaptic terminal 
area and supernumerary synaptic boutons (Figures 4.3 and 4.4). Blocking mGluR 
signaling by genetically removing DmGluRA or treating animals with the mGluR 
antagonist MPEP rescues the branch number defects, but has no significant 
effect on synaptic area defect. Moreover, although the dmGluRA single null 
mutant displays the opposing phenotype of decreased synaptic bouton number, 
both double null mutants and MPEP-treated dfmr1 animals actually display a 
more severe increase in synaptic bouton number. This complex interaction clearly 
supports a relationship between dFMRP function and DmGluRA signaling in the 
regulation of presynaptic architecture, but suggests that this relationship is not a 
simple direct upstream-downstream signaling cascade. Rather, dFMRP function 
is likely controlled by several converging intercellular signaling pathways, of 
which DmGluRA-mediated glutamatergic synaptic signaling is only one. Some of 
the synaptic structuring mechanisms may involve overlapping dFMRP and 
DmGluRA functions, while others likely involve quite independent pathways that 
can converge at multiple levels.  
A similar conclusion derives from our ultrastructural studies of presynaptic 
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differentiation. dFMRP clearly plays critical roles in the regulation of synaptic 
vesic
tered vesicle pool. These findings reinforce the 
conc
le pools; dfmr1 null mutants display elevated overall synaptic vesicle density, 
an increased pool of clustered vesicles at active sites and an elevated number of 
docked vesicles at the presynaptic membrane (Figure 4.5). These defects provide 
a mechanistic explanation for the elevated presynaptic glutamate release that we 
previously characterized at this synapse (Zhang et al. 2001). In addition, many 
presynaptic protein transcripts have been identified as putative direct targets of 
FMRP binding, including MUNC-13, NAP-22, SEC-7 and RAB-5 (Brown et al. 
2001; Miyashiro et al. 2003). Several of these encoded proteins are known to play 
important roles in vesicle cycling and trafficking, consistent with the presynaptic 
vesicle defects reported here in dfmr1 mutants. In contrast, DmGluRA plays no 
detectable function in the modulation of any of these vesicle pools (Figure 4.5). In 
mammalian system, although Group II/III mGluR signaling has been implicated in 
vesicular endocytosis and exocytosis cycling in the presynaptic terminal, there is 
similarly no evidence that loss of mGluR signaling results in defects in presynaptic 
vesicle pools (Hay et al., 2001; Pamidimukkala and Hay, 2001; Zakharenko et al., 
2002). The most important finding here, however, is that the dfmr1 defects can be 
rescued simply by blocking DmGluRA signaling in double null mutants (Figure 
4.5). Removing DmGluRA function significantly rescues the defects in both the 
total synaptic vesicle pool and clus
lusion that dFMRP and DmGluRA functions must intersect in the regulation 
 150
of presynaptic properties, in both structuring and functional manifestations. 
Fragile X Syndrome is a mental retardation disorder, and therefore it is 
obviously critical to move into the brain and assay similar functions in neuronal 
circuits relevant to learning and memory. In Drosophila, the relevant brain region 
is the Mushroom Body, a well-characterized center of learning and memory 
consolidation (Heisenberg 1998; Heisenberg 2003). We have shown previously 
that all classes of MB neurons display a cell-autonomous requirement of dFMRP 
in mediating correct axonal patterning (Pan et al., 2004). In the absence of 
dFMRP, these learning circuit neurons display improper axonal growth and 
branching, and strong defects in presynaptic connectivity (Figure 4.6). Similarly, 
mammalian FMRP is localized in the axon process and growth cone in mouse 
hippocampal neurons (Antar, Afroz et al. 2004; Antar, Li et al. 2006) and loss of 
FMRP results in excess axonal filopodia and altered motility of the axonal growth 
cone (Antar et al., 2006). Moreover, recent studies in mouse brain hippocampal 
slices mosaic for FMRP expression have revealed that presynaptic axons 
lacking FMRP form fewer functional presynaptic terminals than control axons 
(Hanson and Madison, 2007). Thus, mammalian FMRP and dFMRP clearly play 
conserved roles is establishing correct presynaptic connectivity in the brain. 
We do not have similar knowledge of the roles of DmGluRA signaling in the 
brain. Technical limitations with the MARCM clonal technique mean that 
comparable studies are not possible for dmGluRA null MB neurons, so we do not 
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know whether there are dmGluRA single mutant defects in related presynaptic 
mechanisms. Moreover, the MARCM technique does not allow us to pursue the 
same powerful double mutant analyses we performed at the NMJ. Therefore, we 
are limited to blocking DmGluRA signaling by treating MARCM clonal animals 
with the mGluR antagonist MPEP, in order to pharmacologically block mGluR 
signaling. The most important finding here, however, is that the dfmr1 defects can 
be rescued simply by blocking mGluR signaling (Figure 4.6). MPEP treatment 
significantly rescues both the increased axon branching and presynaptic axon 
overgrowth that would otherwise occur in dfmr1 null mutant neurons. This single 
cell level finding is consistent with a previous report that treating dfmr1 null 
animals with MPEP rescues the gross anatomical defect of MB axonal lobe fusion 
(McBride et al. 2005). This MPEP-treatment rescue shows that an overlapping 
mechanism exists between mGluR signaling and FMRP function in regulating 
neuronal circuit architecture in central nervous system.  Thus, the results in both 
the peripheral and central presynaptic processes consistently support a 
mechanistic interaction between mGluR and FMRP in controlling presynaptic 
structure and differentiation. 
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Experimental Procedures 
 
Drosophila Genetics 
All Drosophila stocks were maintained at 25oC on standard food under 
standard conditions. The P-element imprecise excision dmGluRA112b null mutant 
was used as the dmGluRA single mutant, and dmGluRA2b (hereafter called 2b), a 
p-element precise excision line from the same screen, was used as its genetic 
background control (Bogdanik, Mohrmann et al. 2004). The w1118; dfmr150M and 
w1118; dfmr13 null mutant strains were used as two independent dfmr1 single 
mutants, with w1118 as the genetic background control (Zhang, Bailey et al. 2001; 
Dockendorff, Su et al. 2002). For all assays involving dmGluRA and dfmr1 
mutants, both dfmr1 alleles were back-crossed into the 2b genetic background, to 
generate a common background for all single and double mutants. Several 
multiply mutant strains were generated for this study: 1) the dfmr150M; 
mGluRA112b and dfmr13; dmGluRA112b double null mutants, and 2) the dfmr150M; 
2b and dfmr13; 2b genetic ba inations. For drug treatment 
studi
d
ckground control comb
es, MPEP, a generous gift from Fragile X Foundation, wass dissolved in 
ddH2O, and added to standard fly food to final concentration 86μM as previously 
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reported (McBride et al. 2005).  
 
Immunocytochemistry  
Wandering 3rd instar ndard saline, followed by 
% paraformaldehyde fixation for 30 mins (for staining dFMRP, HRP and DLG) or 
 mins (for staining DmGluRA). The monoclonal mouse 
antib
larvae were dissected in sta
4
Bouin’s Fixative for 30
ody against dFMRP (6A15; Sigma) was used at 1:1000. The monoclonal 
mouse antibody against DLG (4F3; used at 1:500) was obtained from the 
Developmental Studies Hybridoma Bank (University of Iowa). The Texas 
Red-conjugated anti-Horseradish Peroxidase (HRP; used at 1:200) was from 
Jackson. All primary antibodies were visualized using fluorescent dye-conjugated 
secondary antibodies, including Alexa Fluor 488 goat anti-mouse IgG (1:200; 
Molecular Probes) and cy3-conjugated goat anti-mouse IgG (1:200; Jackson). All 
fluorescent images were collected using a Zeiss LSM 510 meta laser scanning 
confocal microscope and Zeiss image-collection software. All image processing 
was done with Adobe Photoshop 7.0. 
 
Immuno-Electron Microscopy 
Wandering 3rd instar larvae were processed by adapting published methods 
(McDonald, 1999; Edelmann, 2002; Spehner et al., 2002). Dissected larvae were 
fixed for 1 hr in 4% paraformaldehyde plus 0.5% glutaraldehyde, rinsed in PBS for 
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6 mins, and passed through an ethanol series (50%, 70%, 100%; 20 mins each). 
1:1 propylene oxide: araldite was used as a transition media to 100% araldite. 
 embedding mold and cured overnight in a 60oC oven. 
Gold
 regular food to the wandering 3rd instar 
rval stage. All assays were done at room temperature (RT). Before every assay, 
 placed at RT for 2 hrs to acclimatize. For the 
assa
Tissue was placed in a flat
 thin sections were obtained from Leica UCT Ultracut microtome, using 
200-mesh nickel grids on which to collect sections. Grids were blocked for 15 
mins with 1% BSA in DPBS, and incubated overnight at 4oC in either DmGluRA or 
dFMRP primary antibody. Grids were washed for 1 hr in DPBS with Tween-20, 
and for 15 mins in TRIS buffer with 0.05% Tween-20, blocked for 15 mins with 1% 
BSA in TRIS buffer, and incubated for 1 hr at room temperature in secondary 
antibody conjugated to 10 or 25nm gold particles (1/50 dilution). Grids were 
washed for 15 mins in TRIS buffer + 0.05%, washed again for 15 mins in dH2O, 
and blotted dry. Sections were stained with uranyl acetate and lead citrate, and 
imaged as for TEM. 
 
Behavior Assay 
Animals were cultured at 250C in
la
larvae and test agar plates were
y, an individual animal was placed on the agar plate, and allowed to move 
freely for 2 mins. Using a soft brush, the test animal was then rolled over to a 
completely inverted position, as defined by the ventral midline. The time that the 
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animal spent to totally right itself was recorded. Three assays were done for each 
animal, and then averaged to produce one data point. Statistical analysis was 
done using GraphPad InStat 3 software. Significance levels in figures were 
represented as 0.001<P<0.05(*); 0.0001<P<0.001(**); P<0.0001(***). All error 
bars represent Standard Error of Mean (SEM), appropriate for comparison of the 
mean of means distribution. 
 
NMJ structure quantification 
All images used in NMJ structure quantification were 3D-projections from 
complete Z-stacks through the entire NMJ. The lateral, longitudinal muscle 4 in 
abdominal segment A3 was used for all quantification. Data from the two-paired 
hemisegments were averaged for each animal, to produce each single data point. 
Synaptic boutons were defined according to HRP (presynaptic) and DLG 
ostsynaptic) staining. Branches originating directly from the nerve entry point 
imary braches, and each higher order branch was counted only 
when
(p
were defined as pr
 two or more boutons could be observed in a subsequent branch fork. For 
total synaptic area, LSM 5 Confocal Image Examiner software was used in the 
“histogram” display mode. Synaptic regions were user-defined with the closed 
free shape curve drawing tools, defined by the boundary of DLG staining. The 
software output reports the area for each region automatically. Statistical analysis 
was done using GraphPad InStat 3 software. Significance levels in figures were 
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represented as 0.001<P<0.05(*); 0.0001<P<0.001(**); P<0.0001(***). All error 
bars represent SEM, for comparison of the mean of means distribution. 
 
Ultrastructural Analysis 
Wandering 3rd instar larvae were dissected, fixed, sectioned and visualized 
in parallel using standard TEM techniques, as reported previously (Featherstone 
et al., 2001; Haas et al., 2007). Staged animals were dissected in 1XPBS and 
utaraldehyde in 0.05M PBS for 15 mins; replaced 
with 
subsequently fixed with 2.0% gl
fresh 2.0% glutaraldehyde for 1 hr. Preparations were washed three times in 
PBS, transferred to 1% OsO4 in dH2O for 2 hrs, and then washed three times in 
dH2O. Preparations were stained en bloc in 1% aqueous uranyl acetate for 1 hr, 
washed three times in dH2O, dehydrated in an EtoH series (30-100%), passed 
through propylene oxide, transferred to a 1:1 araldite: propylene oxide mixture, 
and embedded in araldite embedding media. Ultra-thin serial sections (50-60nm) 
were made on a Leica UCT Ultracut microtome and transferred to formvar-coated 
grids. Grids were examined and images collected on a Phillips CM10 TEM 
equipped with an AMT 2 mega pixel camera. NMJs were sectioned, and profiles 
for each synaptic bouton were quantified in sections containing only a single 
prominent electron-dense active zone (AZ) and T-bar structure. Synaptic vesicles 
in the “clustered” pool were defined as those within 250 nm of an AZ. Docked 
vesicle were defined as those <0.5 vesicles diameter (<20 nm) from the 
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electron-dense plasma membrane at the AZ. Measurements and quantifications 
were made using Image J 1.32j free software from NIH. Each profile was scored 
r bouton/mitochondria area, and the number of docked, clustered vesicles and 
rrected for mitochondria area). Mean quantified 
param
fo
total vesicle density (co
eters were statistically compared using the Mann-Whitney test, and 
presentation images were processed in Adobe Photoshop. 
 
Mushroom Body MARCM analysis 
The Mosaic Analysis of Repressible Cell Marker (MARCM) clonal technique 
was employed as first described in Lee and Luo (1999). Single neuron MARCM 
clones were made in the brain Mushroom Body, within the population of γ neurons. 
Staged embryos were collected within a 4 hrs window and cultured at 25oC. 
Mature embryos at 20 hrs were heat-shocked at 37oC for 1 hr to induce 
recombination and clone formation. Animals were then cultured to maturity at 
25oC. Adult brains were dissected out within 1 day following eclosion. Brains were 
dissected in 1XPBS, fixed in 4% paraformaldehyde for 30 mins and processed 
with immuno-staining. MB axon lobe was labeled by mouse anti-Drosophila 
Fasciclin II 1D4 (1:20, Developmental Studies Hybridoma Bank, University of 
Iowa), and the MARCM clone was labeled by rat anti-mouse CD8 (1:100, Caltag). 
Primary antibodies were visualized using Cy3-conjugated goat anti-mouse IgG 
(1:100, Jackson), and FITC-conjugated goat anti-rat IgG (1:100, Jackson). For 
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g GraphPad InStat 3 
oftware. Significance levels in figures were represented as 0.001<P<0.05(*); 
ll error bars represent SEM, for comparison 
of the
γ-neuron axonal quantification, the primary axon branch was identified first as the 
single projection joined γ-lobe, and all other axon processes extended from this 
main trunk were counted as branches. The length of each branch was measured 
based on 3D-projections from complete Z-stacks from confocal microscopy. All 
branch lengths of single axon branches were added together to obtain the total 
cumulative axon length. Statistical analysis was done usin
s
0.0001<P<0.001(**); P<0.0001(***). A
 mean of means distribution. 
CHAPTER V 
 
SUMMARY AND FUTURE DIRECTIONS 
 
In this thesis, I described my work of using Drosophila model to study cellular 
and molecular mechanisms of Fragile X Syndrome.  
First, using MARCM technique, I assayed single cell architecture of 
Mushroom Body neurons in the intact Drosophila brain. In dfmr1 null mutant 
neurons, cell bodies extend supernumerary projections, and both dendrites and 
axon display overgrowth and overbranching compared to wild type. Consistently, 
over-expression of dFMRP in MB neurons results in simpler structure, including 
more clean cell bodies, undergrowth and underbranching in dendrites and axons. 
Ultrastructure analysis shows enlarged synaptic bouton size, and abnormal 
vesicle accumulation in dfmr1 synaptic boutons, which indicate altered 
synaptogenesis and arrested synaptic function. These results are consistent with 
former reports about neuronal structure defects in peripheral nerve system in 
dfmr1 mutants. Taking all central and peripheral data together, we can conclude 
Drosophila FMRP is a global negative regulator of neuronal architecture (Figure 
5.1). 
Second, using tissue staining with specific antibodies and fluorescence 
intensity quantification, I investigated the regulatory function of dFMRP on the  
 160
  
 
 
 
 
 
Figure 5.1 dFMRP is a global negative regulator of neuronal architecture  
In motor neurons, dfmr1 mutant NMJ synapses are overgrown and overbranched, 
while over-expression of dFMRP results in undergrowth and underbranching. In 
sensory neurons, dfmr1 null dendrites display terminal-overelaborated, while 
over-expression causees opposite phenotypes. In central nervous system, dfmr1 
mutant cell bodies extend more excess projections, and both dfmr1 null dendrites 
and axon display overgrowth and overbraching phenotypes, while 
over-expression dFMRP simplifies the neuronal architecture. This figure is cited 
from Zhang and Broadie, Trends in Genetics, 2005. 
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Ionotropic glutamate receptors (iGluR) at the Drosophila NMJ synapses, and the 
hypothesized relationship between dFMRP function and metabotropic glutamate 
receptor signaling. I found that dFMRP regulates two iGluR classes in opposite 
directions. The A-class receptor population is increased, while B-class is 
decreased in dfmr1 mutants, consequently resulting in strong increase of A- to B- 
class receptor ratio. Over-expression dFMRP targeted to either pre- or 
post-synaptic terminals indicate that the regulatory function of dFMRP on iGluRs 
is postsynaptic. In contrast, DmGluRA negatively regulates both iGluR classes in 
common. Both A- and B- iGluR classes are increased in dmGluRA mutants. 
Over-expression assays indicate that DmGluRA functions in both pre- and post- 
synaptic terminals. Postsynaptic over-expression of DmGluRA displayed opposite 
changes of the iGluR population compared to dfmr1 null, which suggested an 
overlap between dFMRP function and DmGluRA signaling in the postsynaptic 
compartment. Targeted rescue of dFMRP expression in the presynaptic neuron 
didn’t rescue iGluR expression level changes, which further demonstrated that 
dFMRP acts in the postsynaptic terminals to regulate iGluR expression. Double 
mutants of dfmr1 and dmGluRA always displayed an additive effect of the two 
single mutants, which suggests independent, convergent pathways between 
dFMRP and DmGluRA regulation. Taken together, both dFMRP and DmGluRA 
regulate synaptic expression level of ionotropic glutamate receptors at Drosophila 
NMJ. While dFMRP functions in a class-specific way and in postsynaptic 
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terminals, DmGluRA signal regulates total iGluR level and functions in both pre- 
and post- synaptic terminals. There is overlap between dFMRP function and 
DmGluRA signal at postsynaptic side, however independent pathways of these 
two proteins also exist (Figure 3.9 B). 
In the third part of this thesis, I further examined mechanistic relationships 
between dFMRP and the sole Drosophila mGluR (DmGluRA) by assaying protein 
expression, behavior and neuron structure in brain and NMJ; in single mutants, 
double mutants and with an mGluR antagonist. At the protein level, dFMRP is 
upregulated in dmGluRA mutants, and DmGluRA upregulated in dfmr1 mutants, 
demonstrating mutual negative feedback. Null dmGluRA mutants display defects 
in coordinated movement behavior, which are rescued by removing dFMRP 
expression. Null dfmr1 mutants display increased NMJ presynaptic structural 
complexity and elevated presynaptic vesicle pools, which are rescued by blocking 
mGluR signaling. Null dfmr1 brain neurons similarly display increased presynaptic 
architectural complexity, which is rescued by blocking mGluR signaling. These 
data show that DmGluRA and dFMRP convergently regulate presynaptic 
properties. 
Taken together, my work has clarified the cellular function of dFMRP on 
neuronal architecture, uncovered new molecular mechanisms showing that 
dFMRP regulates class-specific ionotropic glutamate receptor levels in synaptic 
terminals, and elucidated the mechanistic relationship between dFMRP function 
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and DmGluRA signaling. 
 
Functional relationship between dFMRP and DmGluRA 
Although behavioral and neuron morphological assays suggest that both 
overlapping and independent mechanisms exist between dFMRP and DmGluRA, 
more experiments should be done to further dissect this connection.  
Ultrastructure analysis showed increased presynaptic vesicle density in 
dfmr1 mutant synaptic boutons in both CNS and NMJ synapses (Chapter II and 
IV), which suggests defective synatogenesis and/or plasticity. At NMJ, this vesicle 
density increase can be rescued by deleting DmGluRA signaling. In addition, both 
dfmr1 and dmGluRA mutants display increased synaptic plasticity at NMJ. At 
dfmr1 null NMJ, evoked EJC is increased, and both amplitude and frequency of 
spontaneous release are enhanced (Zhang et al., 2001). In contrast, dmGluRA 
mutants display normally basal synaptic transmission, but synaptic facilitation 
during short-term stimulus is significantly increased (Bogdanik et al., 2004). It 
would be interesting to know the performance of dfmr1; dmGluRA double mutants 
in functional assays. Moreover, the connections among these results, which would 
be generated from neuronal architecture assay, electron microscopy, and 
electrophysiological examinations, may provide a deeper view of the functions of 
dFMRP and DmGluRA. 
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Potential downstream pathways of dFMRP in postsynaptic terminals 
In chapter III of this thesis, I showed that dFMRP regulated ionotropic 
glutamate receptors in a class-specific mechanism. Regulating GluR class 
composition in the postsynaptic domain is an important mechanism for controlling 
neurotransmission strength and synaptic plasticity properties. The subunit 
composition of mammalian NMDA and AMPA receptors are both known to be 
regulated in this fashion (Sheng et al., 1994; Washburn et al., 1997). Similarly at 
the Drosophila NMJ, the independent regulation of GluR classes is critical, since 
each receptor class has distinct functional properties (DiAntonio, 2006). The 
molecular mechanisms for controlling each GluR therefore must be distinct. 
dFMRP, like its mammalian counterparts, is an RNA-binding protein and a 
regulator of protein synthesis. However, there is no evidence to show that any 
subunit of ionotropic GluRs is a direct target of FMRP. So dFMRP likely regulates 
iGluR synaptic expression levels by regulating the translation of important factors 
upstream of iGluR localization. Presumably, these translation regulatory 
mechanisms underlie the differential, and opposing, regulation of A- and B-class 
GluRs by dFMRP (Figure 5.2). 
At the Drosophila NMJ, distinct mechanisms regulating specific iGluR 
classes have been identified. For example, the A-class GluR specificity is 
negatively regulated by the Drosophila protein kinase A (PKA) phosphorylation, 
modulated by α-protein kinase C (α-PKC). This specificity is important because 
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the A-class receptor mediates retrograde signaling and displays larger, 
slower-decaying transmission events with a smaller single channel conductance 
(Petersen et al., 1997; Davis et al., 1998; DiAntonio et al., 1999; Ruiz-Canada et 
al., 2004; Chen et al., 2005). Moreover, the Drosophila the Rho-type GEF, dPix 
(Werner and Manseau, 1997; Hakeda-Suzuki et al., 2002), its interacting 
Drosophila p-21 activated kinase (dPak), a serine threonine kinase activated by 
GTPases Rac and Cdc42 (Harden et al., 1996; Newsome et al., 2000; Mentzel 
and Raabe, 2005), and a dPak binding partner, the adaptor Dreadlocks (Dock; 
Nck homolog) (Rao and Zipursky, 1998; Buday et al., 2002; Ang et al., 2003; Rao, 
2005), are all required to facilitate synaptic expression of A-class GluRs, but 
GluRIIB is reportedly not affected in mutants of this pathway (Parnas et al., 2001; 
Albin and Davis, 2004). Trafficking mechanisms likely involve GluR tethering to 
the cytoskeleton. The actin-interacting Coracle (mammalian brain 4.1 protein) 
binds only GluRIIA to specifically regulate its abundance, with no role in B-class 
GluR tethering (Chen et al., 2005). Interestingly, one recent report showed PAK 
directly interacts with FMRP in mouse brain, and inhibition of PAK activity can 
rescue abnormal dendritic spine morphology and some behavioral defects in fmr1 
knockout mice (Hayashi et al., 2007). Therefore, it will be interesting to examine 
the relationship between dPix-dPak pathway and dFMRP function, as well as 
interaction between PAK and dFMRP. These work should answer the question of 
which down-stream mechanism dFMRP regulates A-class iGluR expression. 
  
 
 
 
 
 
 
 
 
Figure 5.2 Distinct mechanisms regulating A- and B- class iGluRs 
A-class GluRs are negatively regulated by PKA phosphorylation, and modulated 
by α-PKC. dPix and dPAK interact with each other and both regulate synaptic 
expression of A-class iGluRs. Another factor in this pathway is Dock, a binding 
partnet of PAK. DLG is a PDZ-domain scaffolding protein involved in the specific 
localization of B-class GluRs. CamKII plays a role to regulate DLG activity. 
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There are also some specific mechanisms known to be involved in B-class 
iGluRs synaptic localization. For example, the PDZ-domain scaffold Discs Large 
(DLG), a mammalian postsynaptic synaptic density protein 95 (PSD-95) 
homologue, is involved in the localization of many synaptic proteins (Lahey et al., 
1994; Budnik et al., 1996; Guan et al., 1996; Tejedor et al., 1997; Thomas et al., 
1997; Thomas et al., 2000; Mathew et al., 2002; Roche et al., 2002), and plays a 
specific role in B-class iGluR regulation: GluRIIB abundance correlates with DLG 
level (Chen et al., 2005), but GluRIIA localization is unaffected in dlg mutants. In 
addition, the synaptic translation of PSD-95 is regulated by both mGluR signaling 
and FMRP in mouse hippocampus (Todd et al., 2003; Ferrari et al., 2007). 
PSD-95 mRNA is also identified as a direct target of FMRP, and FMRP may 
regulate the stability of PSD-95 mRNA (Zalfa et al., 2007). Another potential 
candidate is Ca2+/calmodulin-dependent protein kinase II (CamKII), which plays a 
role in regulation of DLG activity (Beumer et al., 2002). Mammalian α-CamKII 
subunit mRNA has been identified as a direct target of FMRP; and FMRP 
regulates the translation of α-CamKII by interaction with the small dendritic 
non-translatable RNA BC1 (Zalfa et al., 2003). Thus, more work examining the 
relationship between dFMRP function and CamKII-DLG pathway is also a 
potentially important direction.  
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Pre- and Post- synaptic regulation by dFMRP 
FMRP is mostly localized in neuronal soma, with a much lower expression 
level in neuronal processes and synapses. As an RNA-binding protein and 
translational regulator, mammalian FMRP displays affinity to about 4% of total 
brain mRNA (Brown et al., 1998; Brown et al., 2001). Microarray analysis has 
identified hundreds of potential direct mRNA targets of FMRP binding and 
translational regulation, which suggested a global function of FMRP (Brown et al., 
2001). Although several interactive factors and direct downstream targets of 
FMRP have been identified in past few years (Bagni and Greenough, 2005; 
Zhang and Broadie, 2005), these represent but still a drop in the bucket compared 
to the long list of potential candidates. It is reasonable to predict more interactive 
factors and more mRNA targets will be found, which will provide us a broader view 
of FMRP functions. Even if we only consider the already established co-worker 
proteins and mRNA targets, the diversity suggests that FMRP is involved in 
multiple pathways, in which the mGluR hypothesis expostulate the most attractive 
and the most studied one, but not the only one. 
The mGluR theory is about postsynaptic cooperation between FMRP and 
mGluR in regulating ionotropic GluR levels to alter the synaptic plasticity (Bear et 
al., 2004). The abnormal dedritic spines in cortex and decreased specific LTD in 
hippocampus both suggested a strong postsynaptic function of FMRP (Bear et al., 
2004). In the chapter III of this thesis, I found that dFMRP regulates iGluR level in 
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the NMJ synapses by a similar postsynaptic mechanism. Both FMRP and FMR1 
mRNA are localized in dendritic processes and dendritic spines, and this 
localization responds to mGluR activation (Antar et al., 2004; Antar et al., 2005). 
So, the postsynaptic mechanism of FMRP is clearly supported. 
However, if we extend our scope outside postsynaptic terminals, there is also 
growing evidence for presynaptic pathways regulated by FMRP function. 
Identification of FMRP mRNA targets has mostly suggested presynaptic functions. 
The most notable target group is cytoskeleton control pathways. A key function of 
FMRP/dFMRP appears to be regulating microtubule and actin filament dynamics 
via regulating expression of key cytoskeleton-binding proteins, such as 
Futsch/MAP1b (Zhang et al., 2001; Lee et al., 2003; Schenck et al., 2003; Lu et al., 
2004; Antar et al., 2006), Arc/Arg3.1 (Zalfa et al., 2003), Ca2+/calmodulin- 
dependent protein kinase II (Zalfa et al., 2003) and the small GTPase Rac1 (Lee 
et al., 2003). An interesting interactive factor of FMRP, CYFIP/Sra-1, also plays a 
role in regulating cytoskeleton (Schenck et al., 2003). In the nervous system, 
dFMRP acts as a negative translational regulator of Futsch, the Drosophila 
homologue of MAP1B (Zhang et al., 2001). In fmr1 knockout mouse hippocampus, 
MAP1B is upregulated and microtubule stability is enhanced (Lu et al., 2004). 
These results predict that the neuronal microtubule cytoskeleton should be 
hyperstabilized in fmr1 mutants. Hyperstabilization of microtubules is known to 
result in the formation of supernumerary processes, excess branching and 
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overgrowth (Gordon-Weeks and Fischer, 2000; Buck and Zheng, 2002; Dehmelt 
et al., 2003): strikingly reminiscent of all of the documented dfmr1 mutant 
phenotypes. Alteration of cytoskeleton dynamics/stability would provide a likely 
direct explanation for defects in neuronal architecture in fmr1 mutants.  
In chapter IV of this thesis, I found blocking mGluR activity by deleting 
mGluR expression or receptor antagonist treatment can only rescue part of 
neuron morphological defects. Increased bouton number and increased total 
synaptic area can be rescued by blocking mGluR signaling, which suggests that 
the cooperation between dFMRP and DmGluRA is not the only affected pathway 
in dfmr1 mutants. However, in our former work, we showed dfmr1; futsch double 
mutation can rescue all morphological defects of dfmr1 single null at NMJ (Zhang 
et al., 2001). Thus, clarifying regulatory function of FMRP on cytoskeleton 
dynamics/stability would be the attractive directions in future work. While several 
cytoskeleton associated proteins have been identified as direct targets or 
co-worker proteins of FMRP, direct evidence proving FMRP regulates 
cytoskeleton dynamic or stability is still limited. More work, for example, on live 
imaging of microtubule and actin remodeling in fmr1 mutant neurons, especially in 
vivo examination, should provide a deeper understanding of FMRP function on 
cytoskeleton regulation and neuronal elaboration. 
FMRP is also detected in axon processes and growth cone in cultured 
neurons of mouse hippocampus (Antar et al., 2004; Antar et al., 2006). Lots of 
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presynaptic proteins have been identified as direct targets of FMRP, including 
MUNC-13, NAP-22, SEC-7 and RAB-5 (Brown et al., 2001; Miyashiro et al., 2003). 
MAP1B, as the best proven mRNA target of FMRP, is also localized in axon and 
growth cone of same culture, with similar localization of FMRP (Antar et al., 2006). 
Hyperabundance of filopodia is found in fmr1 knockout neurons (Antar et al., 
2006). These data suggested a presynaptic mechanism of FMRP to control axon 
growth and synaptic elaboration. In Drosophila central neurons, I similarly found 
increased presynaptic bouton size and enhanced synaptic vesicle density, which 
suggests defects in synaptogenesis and synaptic plasticity (Pan et al., 2004). In 
the NMJ synapses, both spontaneous release quantal size and quantal frequency 
are increased (Zhang et al., 2001). While changed quantal size always represents 
a postsynaptic alternation, the quantal frequency is usually due to the presynaptic 
changes. These functional data suggests both pre- and postsynaptic mechanisms 
of dFMRP function. Our finding that dFMRP specifically regulates different iGluR 
classes in postsynaptic terminals at NMJ might be one explanation of increased 
quantal size. Loss of dFMRP results in significant increased A-class with 
decreased B-class iGluRs, which mimic the over-expression of GluRIIA subunits 
(DiAntonio et al., 1999). This A-class over- expression situation results in 
significant increased quantal size. However, presynaptic mechanisms of dFMRP 
are still waiting for elucidation. One potential mechanism is FMRP regulates 
synaptic vesicle release or cycling. It will be interesting to know whether 
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endocytosis or exocytosis level is changed in fmr1 mutants. If this is demonstrated, 
the next question would be which proteins are regulated by FMRP in presynaptic 
terminals, and which pathways are FMRP involved in to regulate neuronal 
transmission from presynaptic side. 
Since FMRP is an mRNA-binding protein, which does not have solo direct 
target, I believed that more and more detailed mechanisms about FMRP functions 
will be found, which can elucidate the Fragile X Mental Retardation disease 
situation and broaden our view of how our nervous system make its function. 
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